













This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
 
This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
When referring to this work, full bibliographic details including the author, title, 










Investigating the role of MyD88-NF-kB 
signalling in regulating the inflammatory 

















Chronic inflammation has long been considered an enabling characteristic of 
the cancer microenvironment. The release of growth and survival factors, 
extracellular matrix-modifying enzymes and other bioactive molecules by 
inflammatory cells into the tumour microenvironment contributes to the 
acquisition of cancer hallmark capabilities. It is now known that oncogenes can 
activate signals that promote the formation of an inflammatory 
microenvironment, even in the absence of external stimuli, placing 
inflammation as an early phenomenon in the timeline of tumour development. 
The over-expression of an oncogene in pre-neoplastic cells has been shown 
to promote the release of cytokines and other pro-inflammatory markers and 
consequent recruitment of neutrophils and macrophages. The recruitment of 
neutrophils has been previously associated with increased proliferation of 
oncogene-transformed cells, however, the mechanisms by which neutrophils 
exercise this trophic role are yet poorly understood. 
Nuclear factor kappa B (NF-kB) transcription factors are crucial elements for 
the regulation of inflammation, immune response as well as cellular stress 
response. Activation of NF-kB signalling pathway leads to the expression of 
mitogenic and anti-apoptotic factors, thus having the potential to promote 
tumorigenesis.  
MyD88 is an adaptor protein that mediates TLR/IL-1-R activation of the NF-kB 
pathway. MyD88 has been shown to play both positive and negative roles in 
cancer development. It is unclear however, whether the MyD88-NF-kB 
signalling pathway plays a role during the earliest stages of preneoplastic 
development of tumour initiation. 
To better understand the role of MyD88-NF-kB in oncogene driven 
inflammation during preneoplastic cell development, I was involved in the 
development of a zebrafish (Danio rerio) tissue specific inducible model which 
allowed the temporal control of HRasG12V oncogene expression for generation 
of pre-neoplastic cells (PNCs) and the detection of the earliest signalling 
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events that initiate the process of tumour development. Using reporter lines, 
generated elsewhere, I demonstrate the activation of MyD88-NF-kB signalling 
pathway in both PNCs and recruited neutrophils. I also evaluate the effect of 
its downregulation, through the expression of the murine dominant negative 
mutant of IkBa, on PNCs proliferation and modulation of recruited neutrophil 
behaviour. 
Alongside the study of NF-kB as an inducer of tumour initiation, I also provide 
evidence of heterogeneity within the neutrophil population recruited to the 
PNCs and the different behaviours they exhibit. 
This work demonstrates the potential of zebrafish for the study of tumour 
initiation highlighting the involvement of NF-kB signalling pathway in the 
establishment of an inflammatory milieu that allows the progression of this first 





Chronic inflammation has long been considered an enabling characteristic of 
cancer. Inflammatory cells can be activated to infiltrate tumours and release 
signals which exacerbate the aggressiveness of the disease. Nuclear factor 
kappa B (NF-kB) is known as one of the main components to regulate the 
release of these signals and was shown to have enhanced activity in several 
malignancies of distinct origins. Even though much is known in well-
established tumours, the difficulty of early detection of tumour masses 
rendered the study of inflammation in tumour initiation inaccessible.  
The use of zebrafish (Danio rerio) larvae as a model organism has rapidly 
gained popularity within this field of study. The possibility for genetic 
manipulation coupled with the larvae’s translucency allows a non-invasive in 
vivo approach for the study of the initial stages of tumour development.  
This work characterizes the development of a new model, which allows the live 
detection of the earliest events that initiate the process of tumour development 
in the zebrafish larval skin. Live imaging studies revealed the involvement of 
NF-kB in the regulation of the inflammatory response during tumour initiation. 
Genetically blocking NF-kB activation confirmed its tumour promoting role at a 
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1.1 Introduction to Cancer 
 
Cancer is a group of more than 100 distinct diseases which can originate in 
nearly all cell types and organs of the human body, with the most common 
organs affected being lung, female breast, bowel or prostate [1]. The 
underlying characteristic of all cancers is an abnormal and uncontrolled 
proliferative and invasive phenotype whereby cells expand beyond normal 
tissue boundaries and ultimately metastasize to distant organs of the body [2]. 
With millions of new cases arising every year, cancer is responsible for 1 in 7 
deaths worldwide [3]. 
Since the early twentieth century, when Theodore Boveri observed that cancer 
cells were often affected with chromosomal anomalies [4], increasing 
cumulative evidence established that genetic mutations carried within a cell’s 
genome, is the central driving mechanism of all cancers. While a small 
proportion of cancers can be hereditary, 90% of cancers are associated with 
newly acquired  somatic mutations as a result of environmental factors [5]. A 
variety of risk factors have been implicated as potential causes for tumour 
development. Considering cancer arises as the result of somatic mutations 
accumulated through the course of one’s life, the risk of developing this 
disease increases with age. Consequently, 36% of all cancer patients 
diagnosed each year in the UK are over 75 years old [1]. Environmental 
factors, such as, exposure to ionising radiation or mutagenic chemicals, can 
directly affect a cell’s genetic integrity. However, many cancers are often 
associated with some sort of chronic inflammation. Tobacco smoking is 
implicated in approximately 33% of cancer cases. 35% of cases are associated 
with obesity and poor diet. Chronic viral infections are also associated with 
certain types of cancer [1,5]. Considering that some risk factors are associated 
with unhealthy behaviour and life style, it is believed that nearly 40% of cancer 
cases in the UK are preventable [1].  
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Even though all cancers share a common pathogenesis and genetic mutations 
as the central driving mechanism, cancer is a highly heterogeneous group of 
diseases. The multitude of environmental factors, the great variety of gene 
mutations, often with context dependent functional impact, makes each 
disease unique with distinct severities and prognosis [6–8]. Early detection and 
treatment greatly increase the chances of survival. However, by the time 
patients present visible symptoms and report to the clinic, the disease has 
already progressed to a well-established tumour and, occasionally, with 
metastases in distant organs, limiting the available treatment options. 
Therefore, there is limited compiled evidence of the early events of 
carcinogenesis. Given the importance of early detection in improving patient 
outcomes, several funding bodies are starting to prioritize scientific research 
for the development of platforms for early detection and preventive therapies 
[9,10].  
 
1.2  Cancer as a Complex Multistage Disease 
 
The development of cancer is a stepwise process with increasing complexity. 
Tumour development is initiated with the acquisition of mutations in one or 
more somatic cells which give them a proliferative or survival advantage, or 
confer an increased susceptibility to further mutations. With each mutation a 
cell’s aberrant phenotype becomes more prominent and its malignant state is 
enhanced. These aberrant cells promote tumour formation by uncontrolled 
clonal expansion developing cell masses which expand beyond normal tissue 
boundaries [2]. As the disease progresses, cancer cells acquire great 
plasticity. As such, some cells may detach from the primary tumour and spread 
to surrounding and distant organs where they seed the development of 
metastases. 
As a tumour develops, cancer cells are believed to acquire a mutator 
phenotype, becoming more susceptible to additional stochastic mutations and 
chromosomal rearrangements [11,12]. In agreement with this concept, 
sequencing analysis of several tumour types has estimated that most cancers 
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present 1000 to 20000 somatic point mutations and hundreds of insertions, 
deletions and chromosomal rearrangements [13]. 
As such, cancer can be considered an evolutionary process whereby 
progressive hereditary genetic alterations that accompany tumour 
development give rise to a heterogeneous population of abnormal cells subject 
to natural selection. Some cells with metabolic or immunologic disadvantage 
die, while cells that survive and proliferate more efficiently thrive constituting 
the dominant subpopulation until a more advantageous phenotype appears 
[2,14,15].  
While genetic mutations are considered the driving mechanism for cancer 
development, not all mutations acquired by somatic cancer cells have a 
consequent effect on tumour progression. These alterations can be classified 
as driver mutations or passenger mutations. Driver mutations grant the cells 
carrying them a proliferative or survival advantage allowing these cells to 
outcompete their neighbours. Passenger mutations do not confer any 
advantage to the tumour formation but happen to be present in cancer cells 
that are positively selected through the presence of driver mutations [2]. 
Cancer driver mutations often involve genes that regulate homeostatic cell 
processes such as cell polarity, cell cycle progression and proliferation, DNA 
repair and cell death signalling pathways. These genes fall into two different 
categories: oncogenes and tumour suppressor genes. Oncogenes arise from 
gain-of-function mutations in genes which encode proteins involved in the 
positive regulation of cell growth and proliferation, proto-oncogenes [16]. Such 
genes include RAS, EGFR, v-SRC, c-MYC, WNT and ERBB2. Tumour 
suppressor genes arise from loss-of function mutations in genes which control 
anti-tumorigenic mechanisms such as DNA repair and mitotic checkpoints, cell 
senescence and cell death [16]. TP53, PTEN, BRCA1, RB1 and APC are 
examples of tumour suppressor genes. As such, driver mutations will either 
directly enable a cell to proliferate or survive, or make it more resistant to the 
mechanisms which hold its proliferation or survival in check. 
While nearly 300 driver genes have been identified [7], their functional impact 
is confined to a select number of signalling pathways implicated in 
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mechanisms such as cell growth and proliferation, stemness (pluripotency) 
and differentiation, cell survival/death and cell cycle progression, DNA repair 
and genomic integrity [8]. Some of these signalling pathways are often 
associated with specific types of cancer. But a few genes and their respective 
pathways are altered in high frequency across most cancer types. These 
genes include the tumour suppressor genes TP53 and CDKN2A which are 
involved in the DNA Damage Response and cell cycle regulation, respectively. 
Gain-of-function mutations in RAS and EGFR, promoting cell growth and 
proliferation, are also amongst the most common genetic alterations [8,12,17].  
Although both the general principles of the mechanisms driving tumour 
development and the concept of cancer as an evolutionary disease are well 
established, the complexity and diversity between and within different cancer 
types restrict the study of important aspects of this disease. For instance, the 
classification of mutations found in cancer cells is constantly being updated as 
newly discovered cancer genes are added. Moreover, it is not always clear 
which mutations in those genes are, in fact, “drivers” and at which stage during 
tumorigenesis they are acquired [6,7,18]. As such, a long-standing question  
in cancer research has been to determine the minimum number of mutations 
required for the initiation of the tumorigenesis process to take place [13]. A 
recent study by Martincorena and colleagues in 2017 addressed this question, 
concluding that a surprisingly low number of driver mutations, ranging from 1 
to 10 depending on the type of tissue, are required for tumorigenesis [19]. 
The complexity of cancer disease is further exacerbated by the involvement of 
other cell types within the tumour microenvironment. Transformed cells often 
exhibit paracrine signalling and engage surrounding resident and recruited 
cells to redirect their intracellular circuitry to nurture tumour development. 
Through the course of tumour development paracrine signalling promotes 
activation of resident fibroblasts and the recruitment of inflammatory cells. As 
tumour density increases, the recruitment of endothelial cells and vessel 
sprouting are extremely important for the establishment of a vascular system 
to meet the tumour needs for nutrients and oxygen. In this context it is 
important to consider tumours as complex tissues which include not only 
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mutant cancer cells but also the surrounding tumour associated stroma, 
involved in heterotypic interactions with one another to promote tumour 
progression [20–23]. 
With the purpose of formulating a commonality within the diversity and  
complexity of cancers for a better understanding of the development of such 
malignancies, Hanahan and Weinberg envisioned the concept of phenotypic 
capabilities required in most cancers, which they named hallmarks of cancer  
[20,23]. This concept comprises the principle that various driver mutations and 
subsequent altered pathways acquired by cancer cells, as well as the activity 
of the surrounding normal cell types, present a multitude of mechanisms for 
the development of the same underlying features required for the progression 
of the disease (Figure 1.2.1) [20,22,23].  
While these phenotypic capabilities have been extensively studied in well-
established tumours, how they arise and whether they are required for the 





Figure 1.2.1 Hallmarks of Cancer.  Phenotypic capabilities required in most cancers for 
tumour development and progression to metastatic disease as envisioned by Hanahan and 
Weinberg. 
 
(Figure reused from Cell, Volume 144, Issue 5, Douglas Hanahan and Robert Weinberg, 
Hallmarks of Cancer: The Next Generation, P646-674., Copyright (2011), with permission from 
Elsevier) 
   
 7 
1.3 Ras Signalling and Its Role in Cancer 
 
Ras proteins are ubiquitous small GTPases which act as signal-relay proteins 
for several external stimuli, such as growth factors. Amongst the many 
important cell mechanisms they regulate are cell proliferation, differentiation, 
survival, motility [24]. In humans, the family of Ras proteins is composed of 
four highly homologous isoforms: HRas, NRas, KRas4A and KRas4B. These 
proteins are mainly present on the cytosolic surface of the plasma membrane. 
Specific isoforms were shown to exert signal relay in other membrane-bound 
organelles , namely Golgi apparatus (HRas and NRas) and endosomes (HRas 
and KRas) [25]. 
Ras functions as a binary switch, transitioning between the inactive GDP-
bound and the active GTP-bound conformation. Because GDP is generally 
tightly bound and Ras intrinsic GTPase activity is very slow, this 
conformational switch is dependent and regulated by other GTPases [26,27]. 
Specifically, guanine nucleotide exchange factors (GEFs) bind to GDP-bound 
Ras mediating a conformational change which weakens Ras affinity to GDP, 
leading to the latter’s release and the former’s passive binding to GTP, which 
is more abundant in the cytosol, and consequent activation [28,29]. 
Conversely, GTPase-activating proteins (GAPs) bind to GTP-bound Ras and 
accelerate GTP hydrolysis by stabilising its high-energy transition state 
through the insertion of a catalytic residue, switching Ras back to its inactive 
GDP-bound form [28,30]. Given that the signalling network downstream of Ras 
and, consequently, the final signal output of a cell is greatly determined by the 
intensity and duration of Ras activity [24,31], a tight regulation of GEFs and 
GAPs is in place to mediate the appropriate Ras responsiveness to a multitude 
of stimuli. While this regulation is extremely important, it is mainly dependent 
on the mechanism of translocation, as GEFs and GAPs bind and promote Ras 
conformational changes by being recruited to the plasma membrane in close 
proximity with Ras proteins [26]. For instance, the activation of a cell through 
the binding of growth factors to Tyrosine Kinase Receptors (TRK), leads to 
receptor autophosphorylation, creating an intracellular docking site  for adaptor 
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proteins. Amongst these adaptor proteins, Grb2 is recruited in association with 
Sos, a GEF protein, allowing for activation of Ras proteins  and subsequent 
effector pathways [32]. 
To date, more than 10 different Ras effector pathways have been identified. 
The best characterized effector pathway is the Raf-MEK-ERK kinase cascade, 
whereby activated ERK can interact with several cytosolic and nuclear 
proteins, such as transcription factors, and ultimately, have a great effect on a 
cell transcriptional activity [33–36]. Another Ras downstream effector pathway 
involves the activation of PI3Ks and activation of downstream PDK1 and Akt 
kinases [36–38]. Ras-GTP can also bind and activate the signalling cascades 
of RALGEFs [39], Tiam [40], Phospholipase Cε [41], amongst others. 
Collectively, all Ras effector pathways act synergistically to mediate cellular 
responses to external stimuli regulating a wide range of cellular processes, 
including cell cycle progression and cell growth, survival and apoptosis, cell 
adhesion and cell motility, and vesicle trafficking (Figure 1.3.1). 
Whilst all isoforms share regulatory mechanisms and can virtually bind to all 
Ras downstream effectors, their functions in embryo development and cellular 
homeostasis are not completely redundant [42]. The mechanisms attributing 
specific functions to each isoform are not fully understood and still under 
extensive investigation. It has been suggested that the functional singularities 
of Ras isoforms are related to differences in subcellular localization [25,43] and 
in their efficiency at activating distinct downstream effectors [44]. Tissue 
dependent variable expression levels of each isoform could also explain their 
non-redundant functionalities [45]. However, given the complexity of Ras 
signalling networks and how they are differently regulated in a tissue specific 
manner, in vivo evidence of the unique isoform functions is less clear [42,46]. 
Gain-of-function Ras mutations are amongst the most common tumour drivers, 
present in approximately one third of all human cancers [46]. These mutations 
often involve a single amino acid substitution at positions G12, G13 or Q61 
which results in the loss of intrinsic and GAP dependent GTPase activity [47]. 
As a result of these mutations Ras proteins remain constitutively in the active 




Figure 1.3.1 Ras signalling pathway. Downstream Ras effector pathways implicated in Ras 
mediated oncogenesis and the main mechanisms they regulate. 
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downstream effectors. Substitutions in each of the three positions have 
oncogenic potential in all Ras isoforms, however, each Ras isoform mutated 
at specific positions with distinct substitutions, prevail in different types of 
cancer. Namely, KRas mutations are most frequently found in 
adenocarcinomas [46,48], NRas mutations predominate in melanoma and 
haematopoietic malignancies [46,49], HRas mutations are often associated 
with skin squamous cell carcinoma and cancer of the urinary bladder 
[24,46,50]. 
Oncogenic Ras can contribute to the transformed cell phenotype in various 
ways. Considering the role of Ras proteins as regulators of a cell’s response 
to mitogenic signals, it is not surprising that constitutively active Ras has an 
effect on the control of a transformed cell’s proliferation. In fact, not long after 
its discovery, oncogenic Ras has been shown to be sufficient for cell cycle 
progression and increased proliferation of quiescent cells [51,52]. Several 
downstream effectors of Ras seem to contribute to this effect by promoting 
overexpression of cyclinD1 [53]. PI3K signalling further contributes to a cell’s 
proliferative capacity by inhibiting GSK3β dependent proteolysis of CyclinD1 
[54]. The central role of CyclinD1 in oncogenic Ras induced proliferation and 
tumorigenesis has also been established in vivo, whereby CyclinD1-deficient 
mice failed to develop and maintain different types of tumours  [55–57].  
Oncogenic Ras can further potentiate its own mitogenic effects by generating 
an autocrine loop through the overexpression of several growth factors, such 
as HBEGF, and the respective receptors [58,59].  
The role of oncogenic Ras in cell viability is rather complex as it has been 
shown to mediate both, anti- and pro-apoptotic mechanisms. For instance, 
activation of PI3K and Raf pathways promotes cell survival through the 
upregulation of anti-apoptotic factors, such as ARC [60], and downregulation 
of pro-apoptotic proteins, including PAR4 [61]. Inversely, oncogenic Ras was 
also shown to promote apoptosis through a variety of mechanisms, such as 
activation of various tumour suppressor pathways [62,63]. While the 
mechanisms regulating the balance of these opposing signals are not yet fully 
understood, they seem to be context dependent. Nevertheless, in vivo 
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experimental data suggest that during tumorigenesis, oncogenic Ras favours 
a pro-survival signalling output in the presence and absence of tumour 
suppressors [64,65]. This is corroborated by the high incidence of Ras 
mutations found in human cancers.  
The pro-tumorigenic role of constitutively active Ras is not limited to cell 
proliferation and survival as constitutively active Ras has also been shown to 
contribute to cell plasticity and migration through the alteration of cell junctions 
and the actin cytoskeleton [66]. The downstream effects of oncogenic Ras 
signalling are also felt beyond the cancer cell and promote alterations in the 
tumour microenvironment. Oncogenic Ras can contribute to the establishment 
of an inflammatory microenvironment with the release of cytokines and 
chemokines, such as, IL-1a, IL1-b, IL-6, CXCL8, amongst others [67–69]. 
These inflammatory mediators are believed to exert a pro-tumorigenic effect 
mainly through paracrine signalling. More specifically, secreted IL-6 was 
shown to promote angiogenesis by inducing expression of vascular endothelial 
growth factor (VEGF) [68,70]. Ras-induced CXCL8 expression promotes 
tumour infiltration of inflammatory cells, namely neutrophils, and consequent 
recruitment of endothelial cells, facilitating angiogenesis [69]. Ras induced 
upregulation of pro-angiogenic factors promote tumour vascularization. This is 
only achieved with the release of proteases which mediate extensive 
remodelling of the extracellular matrix (ECM) softening the physical 
entrapment of paracrine factors and tumour cells [71]. Therefore, aberrant Ras 
signalling contributes to all stages of cancer progression.  
 
1.4 Tumour Associated Inflammation 
 
The connection between cancer and inflammation has long been considered. 
In the nineteenth century, Rudolf Virchow established this link for the first time 
upon the observation that tumours were frequently found in tissues with 
chronic inflammation and were often infiltrated with inflammatory cells [5,72]. 
Since then, increasing evidence confirmed the importance of inflammation in 
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the generation of a pro-tumorigenic microenvironment that nurtures tumour 
formation.  
Chronic inflammation is known to increase the risk of cancer. The implication 
that a chronic inflammatory microenvironment can increase mutation rate, in 
addition to enhancing the proliferation of mutated cells, elucidates how a 
number of inflammatory conditions predispose individuals to cancer 
development [5]. Moreover, inflammation can also be triggered after tumour 
initiation in a process now recognised as “tumour elicited inflammation”. 
Several mechanisms can contribute to that effect. A few oncoproteins have 
been shown to drive an inflammatory response through the activation of 
signalling pathways that promote the upregulation and release of 
proinflammatory cytokines and chemokines [67,69,72–77]. Inflammation can 
also be promoted by hypoxia and cancer cell necrosis due to insufficient blood 
supply at the core of a tumour mass. In some tissues where the epithelium 
exerts a protective barrier against the external environment, the development 
of a disorganised tumour mass can cause barrier deterioration and microbial 
invasion which can also elicit an inflammatory response [78]. The intensity of 
set inflammation may vary depending on the type of tumour, ranging from 
tumours with low leucocyte density, only detected with the appropriate 
antibodies, to highly chronic inflammatory setting [23]. Regardless of the 
intensity of the inflammatory microenvironment, it is now accepted most 
cancers exhibit an inflammatory component which impacts every step of 
tumorigenesis, from initiation to metastatic progression. In fact, the long term 
intake of non-steroidal anti-inflammatory drugs (NSAIDs) has a well-
recognised preventive effect against several types of cancer [79]. As such, 
“tumour promoting inflammation” has been recognized as one of the hallmarks 
of cancer [23]. 
Many cell types, within the tumour microenvironment, can contribute to the 
establishment of an inflammatory setting. These include, not only, infiltrating 
immune cells, such as neutrophils, macrophages, monocytes, NK cells and T 
and B lymphocytes, but also the cancer cells and cancer associated fibroblasts 
[23]. 
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Mechanistically, inflammation can promote tumorigenesis in various ways, 
contributing for the development of multiple hallmark capabilities. The release 
of inflammatory mediators into the microenvironment can promote tumour cell 
proliferation and cell survival. Inflammatory cells are also major contributors 
for tumour vascularization through the release of pro-angiogenic factors and 
ECM modifiers. Inflammation can equally contribute to tumour progression 
through the release of mutagenic factors, such as reactive oxygen species 
(ROS), which contribute to genetic instability [80–82].  
Finally, inflammation can also have an effect on tumour immune surveillance. 
Most infiltrating immune cells can exhibit both pro- and anti-tumorigenic 
functions and the balance between the immune mediators that promote tumour 
progression opposing anti-tumour immune mediators is the ultimate 
determinant for tumour progression or rejection [83]. Inflammation polarizes 
this balance towards a tumour promoting immunity by enhancing the release 
pro-tumorigenic mediators and by down-regulating immune surveillance 
causing a dysfunctional anti-tumour immunity. Overall, tumour associated 
inflammation functions, not only as a potentiator of tumour progression, but 
also as a protective environment against immune surveillance [83]. 
 
1.5 The NF-kB and MyD88 Signalling Pathways 
 
Nuclear Factor-kappa B (NF-kB) is a family of DNA binding proteins which 
promote transcriptional activation of a multitude of inflammatory and mitogenic 
factors. Given the multitude of external and internal stimuli which can activate 
the NF-kB signalling pathway, as well as the wide range of target genes it 
regulates, NF-kB is considered to play a central role in immune and 
inflammatory responses [84]. 
The NF-kB family of transcription factors include 5 subunits: Rel (cRel), p65 
(RelA), RelB, p105/p50 and p100/p52. These subunits act as homodimers and 
heterodimers for transcriptional regulation. With the exception of RelB, which 
can only form heterodimers with p50 and p52, all other subunits can combine 
in many different dimers. Nevertheless, the most common combination is the 
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heterodimer p65-p50 [85,86]. It is generally agreed that NF-kB activity leads 
to transcriptional activation. However the assembly of p50 and p52 
homodimers can act as transcriptional inhibitors [86–88]. The different 
combinations of subunits which have variable affinities to distinct NF-kB 
binding sites in gene regulatory sequences, and have different mechanisms of 
action, allow for the diversity of responses regulated by NF-kB [89,90]. 
In unstimulated cells, NF-kB dimers are mainly bound to the inhibitor proteins 
from the IkB family, which interfere with the nuclear localization signal (NLS) 
present on NF-kB dimers and thus sequester NF-kB in the cytoplasm. 
Alongside IkBs, NF-kB can also be inhibited by the p100 and p105 proteins, 
precursors to NF-kB p50 and p52 subunits, which also contain an inhibitory 
domain promoting the retention of their partners in the cytoplasm [91]. 
However, while p105 processing into p50 is constitutive, the processing of 
p100 into p52 is regulated [92]. Upon cell stimulation with extracellular stimuli, 
two main pathways lead to nuclear translocation of NF-kB dimers and 
transcriptional activation: the classical (canonical) pathway and the alternative 
(noncanonical) pathway [93]. Both pathways involve similar mechanisms 
including activation of an IkB Kinase (IKK) complex and proteasomal release 
of the NF-kB dimer NLS, although being activated through different cell surface 
receptors and targeting different cytoplasmic adaptors and NF-kB subunits 
(Figure 1.5.1) [93].  
In the classical (canonical) pathway the IKK complex is composed of the 
catalytic subunits IKKα, IKKβ, and the regulatory subunit IKKg or NEMO 
[94,95]. This complex, when active, phosphorylates IkBs targeting 
their polyubiquitination and subsequent proteasomal degradation. The release 
of the NF-kB dimer (mainly p65-p50 in this pathway) from their inhibitor protein 
allows their translocation to the nucleus where they can regulate gene 
transcription [96]. The alternative (noncanonical) pathway activates IKKα 
homodimers which phosphorylate p100, often in a p100-RelB dimer [97]. Once 
phosphorylated, p100 is processed to p52 through ubiquitination and 
proteasomal degradation of its inhibitory C-terminal half. The resulting p52-
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RelB dimer can then translocate to the nucleus to activate gene transcription 
[92]. 
While the alternative pathway is mostly associated with development of 
secondary lymphoid organs, B cell maturation and adaptive immunity, the 
classical pathway is considered a central regulator of innate immunity and 
inflammatory responses. The classical pathway can be rapidly activated by 
pro-inflammatory cytokines, PAMPs and DAMPs acting via TNF, IL-1 and Toll-
Like receptors. Activation occurs within minutes and results in expression of 




Figure 1.5.1 NF-kB signalling pathway, Schematic representation of the canonical and 
alternative pathway for NF-kB activation. (Created with Biorender.com) 
 
The activation of the classical NF-kB pathway occurs mainly through the 
intracellular adaptor protein MyD88. This protein mediates the intracellular 
signalling of IL-1R, IL-18R and all Toll-like receptors (TLRs), with the exception 
of TLR3 [99–102]. MyD88 binds to the cytoplasmic TIR domain of activated 
receptors and recruits IRAK4 [99,102]. IRAK4 autophosphorylation, as a result 
of clustering of MyD88-IRAK4 within the receptor complex, promotes the 
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nucleation of the Mydossome with recruitment of IRAK1 and IRAK2 [103]. The 
Mydossome assembly promotes recruitment and activation of other adaptor 
proteins, including several E3 ubiquitin ligases, such as TRAF6, which 
catalyses K63-linked polyubiquitylation of adjacent proteins [104]. K63-linked 
polyubiquitin is recognised by the regulatory subunit IKKg of the IKK complex, 
which when recruited, induces proximity between the two IKK catalytic 
subunits required for their trans-autophosphorylation and consequent 
activation [104–107]. 
Characteristic target genes of NF-kB signalling include cytokines (such as IL-
1, IL-6 and TNF), chemokines (such as CXCL1, CXCL2 and CXCL8), pro-
inflammatory enzymes (such as COX-2), metalloproteases (MMPs), mitogenic 
signals (such as CyclinD1 and Myc), pro-survival signals (such as BCL-XL, 
BCL-2, SOD2 and cIAPs), inducible nitric oxide synthase (iNOS), NF-kB 
negative regulators (IkBα and A20) amongst others [84,85,93]. 
 
1.6 The  Importance  of  MyD88-NF-kB  Signalling  in  Tumour  
Development 
 
NF-kB is found constitutively active in most cancers, although the mechanisms 
for activation of this signalling pathway greatly vary depending on the type of 
malignancy. Gain of function mutations in several NF-kB subunits and IkBs 
encoding genes have been found in a variety of cancers [108–110]. Similarly, 
cancer driver mutations are also found in genes coding upstream regulators of 
the NF-kB pathway, including TRAF proteins and MyD88 [111–115]. These 
genetic alterations are mainly restricted to haematological malignancies. 
Nevertheless, the majority of NF-kB-positive tumours are solid tumours of 
epithelial nature [116]. 
With regards to epithelial tumours, several studies have revealed a connection 
between oncogenic Ras and NF-kB activation. Several in vitro studies have 
implicated a variety of oncogenic Ras downstream effector pathways in the 
activation of NF-kB signalling and the requirement of NF-kB activity for cellular 
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transformation [69,117–124]. The main mechanism through which NF-kB 
activity seems to mediate cellular transformation is by the suppression of a 
p53-independent oncogenic Ras induced apoptosis [120,125]. This effect 
seems to also be observed in vivo. Suppression of NF-kB signalling leads to 
an increase in apoptosis and reduced formation of KRasG12D induced lung 
tumours independent of p53 status [126,127].  
NF-kB activity can have additional pro-tumorigenic effects by stimulating the 
production of regeneration enhancing inflammatory cytokines and chemokines 
and growth factors, promoting proliferation of tumour cells . As such, increased 
NF-kB activity on its own is sufficient for hyperproliferation and dysplasia of 
the mouse epidermis [128]. Inversely, mice with keratinocyte-specific p65 
deletion are resistant to DMBA/TPA-induced skin carcinogenesis. In this 
model, NF-kB activity has a twofold pro-tumorigenic effect by protecting 
keratinocytes from DNA damage-induced death and by facilitating the 
establishment of a proinflammatory microenvironment which promotes 
epidermal hyperplasia [129]. 
NF-kB dependent cytokine and chemokine production is important to maintain 
NF-kB activation but also to engage other signalling pathways in the process 
of tumorigenesis. IL-1α and IL-1β are important pro-inflammatory cytokines, 
which can be produced by cancer cells and promote activation of the NF-kB 
and MAPK pathways. IL-1α, for instance, was shown to be extremely important 
for a sustained NF-kB activity in HRasG12V transformed keratinocytes through 
the establishment of an autocrine loop through IL-1α-IL-1R-MyD88 signalling 
[130]. The importance of this autocrine loop in skin tumorigenesis is further 
validated by the reduced tumour size arisen from MyD88-deficient HRasG12V 
transformed keratinocytes transplanted into nude mice. MyD88 deficiency did 
not affect tumour cell proliferation or survival but diminished the paracrine 
function of tumour cells, in such manner that tumours displayed impaired 
vascularization [130]. 
Recruited inflammatory cells and cancer associated fibroblasts (CAFs) are 
also major contributors to the establishment of a pro-tumorigenic inflammatory 
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microenvironment in skin carcinomas, through NF-kB-dependent release of 
cytokines and chemokines [131].  
Sporadic colorectal cancer is also highly dependent on MyD88-NF-kB 
signalling for tumorigenesis [132]. This type of cancer is often initiated by loss 
of the APC tumour suppressor gene and consequent activation of β-catenin 
[133,134]. This results in the downregulation of mucin 2 production and 
aberrant expression of tight junction proteins, resulting in intestinal epithelial 
barrier deterioration [78]. As such, the inflammatory microenvironment 
characteristic of this type of tumours is initiated when intestinal epithelial 
barrier deterioration allows the invasion of microbial products, which in turn 
activate resident myeloid cells in a TLR-MyD88 dependent manner. Myeloid 
cells are major contributors for the release of IL-23, IL-1β and IL-6 into the 
tumour microenvironment [78][135]. These cytokines are important for 
tumorigenesis as they promote, directly and through altered adaptive immune 
gene expression, tumour cell proliferation and activation of stem cell markers 
gene expression by activating NF-kB and other inflammatory signalling 
pathways [78,135,136]. 
MyD88-NF-kB signalling has also been implicated in tumorigenesis through 
the activation of immune cell polarization and immunosuppressive behaviour. 
For instance, mobilization and activation of myeloid derived suppressor cells 
(MDSCs) can occur through the activation of IL-1R-MyD88-NF-kB pathway 
[137]. Pro-tumorigenic “M2” macrophage polarization was also shown to rely 
on the same signalling pathway [138,139]. 
While generally accepted as having a pro-tumorigenic role, NF-kB has also 
been shown to exert a tumour suppressor effect in some 
circumstances.  Namely, in diethyl nitrosamine (DEN) driven hepatocellular 
carcinoma NF-kB suppression results in increased hepatocyte death and 
subsequent compensatory proliferation of surviving hepatocytes leading to 
enhanced tumorigenesis [140]. Inactivation of NF-kB in murine skin results in 
spontaneous development of squamous cell carcinomas through the increase 
of keratinocyte apoptosis and TNF-dependent inflammation [141–144]. 
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Therefore, the impact of NF-kB in cancer development is extremely complex, 
having specific effects which may vary depending on cell type, mechanism of 
tumour induction, type of inflammatory response involved in tumour promotion 
or stage of tumour development. 
 
1.7 Neutrophil Recruitment and Their Conflicting Roles in Tumour 
Development 
 
Neutrophils constitute the most abundant leukocytes in circulation and  
represent an organism’s first line of defence against infection and tissue 
damage. These inflammatory cells exert their role in host defence through a 
multitude of mechanisms ranging from phagocytosis to the release of 
antimicrobial materials. They can also modulate other innate and adaptive 
immune responses by the release of cytokines and chemokines and through 
antigen presentation [145]. 
While extensively studied in their role in acute inflammatory responses, 
neutrophils were considered, for a long time, simple bystanders in the 
mechanisms of carcinogenesis and tumour development [146,147]. However, 
since the establishment of inflammation as one of Hanahan and Weinberg’s 
hallmarks of cancer [23], a newfound appreciation for neutrophils and their role 
in tumorigenesis has arisen.  
Several studies have established that neutrophils rely on CXCR2 and CXCR1 
dependent chemotaxis to be recruited to the tumour microenvironment [148–
152]. A number of chemokines upregulated in the tumour stroma have been 
suggested as potential mediators of this neutrophil chemotaxis. CXCL8, a 
known transcriptional target of oncogenic Ras, is known to promote neutrophil 
infiltration [69,74]. CXCL5 was also found to induce neutrophil recruitment in 
hepatocellular carcinoma [153]. As activated neutrophils are also  great 
sources of chemokines they can potentiate neutrophil infiltration through a 
positive feedback mechanism whereby they further promote the recruitment of 
additional neutrophils [147]. Other mechanisms have also been implicated in 
neutrophil chemotaxis. Hydrogen peroxide, for instance, is one of the initial 
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signals promoting neutrophil recruitment to oncogenic Ras transformed cells, 
as it has been shown in a zebrafish model [154]. 
In the tumour stroma, tumour associated neutrophils (TANs) constitute a 
heterogeneous population with conflicting phenotypes. Depending on their 
polarization, neutrophils can exhibit an N1 anti-tumorigenic effect or an N2 pro-
tumorigenic effect [155]. A recent study has further characterized the diversity 
within the neutrophil population in tumour bearing individuals and established 
three distinct populations according to their density and maturity. According to 
the study, mature high density neutrophils resembling neutrophils of tumour 
free animals have an anti-tumorigenic effect. Inversely, low density neutrophils  
are pro-tumorigenic and include a subpopulation of mature (fully formed 
lobulated nucleus) neutrophils and a population of immature neutrophils, 
similar to granulocytic MDSCs [156]. While the characteristic differences of 
these subpopulations are well defined, TANs are able to transition between 
populations in response to tumour derived factors. For example, high density 
neutrophils are capable of becoming low density neutrophils upon treatment 
with TGF-b. Additionally, the low density neutrophil population was found to 
expand with disease progression [156]. 
 In line with these findings, others have also suggested that TAN polarization 
bias is correlated with the stage of tumorigenesis.  TANs from early tumours 
were shown to be more cytotoxic and produce higher levels of TNF, NO and 
H2O2. This effect was progressively reduced with tumour progression and in 
late stage disease TANs mainly exhibited a tumour promoting 
immunosuppressive effect with evident N2 polarized transcriptional signature 
[157–159].  
Nevertheless, recent studies have shown a pro-tumorigenic role of neutrophils 
from an early neoplastic stage [149,150,154,160,161]. Some neutrophil-
derived biomolecules, such as, elastase [162] and MMP9 [163], have been 
shown to exert a direct effect at promoting tumour cell proliferation. However, 




1.8 Zebrafish as a Model Organism in Cancer Research 
 
Zebrafish (Danio rerio) are freshwater tropical fish native to southeast Asia. 
The use of this animal as a model organism for research purposes began in 
the 1960s and for many years it was mainly confined to the field of 
developmental genetics.    
In 1982, the discovery that zebrafish are susceptible to tumour formation upon 
exposure to carcinogens widened the scope of scientific areas to which 
zebrafish could be useful to include cancer research [164]. 
Since then, various studies contributed to the confirmation that the role of 
oncogenes and tumour suppressor genes, as the underlying mechanism of 
carcinogenesis, was conserved across species [165–167]. Following the 
development of powerful transgenesis technologies, a multitude of zebrafish 
models of cancer have been created and contributed to the better 
understanding of all stages of the disease [168,169].  
Due to their genetic tractability and optical transparency, zebrafish larvae 
exhibit an unprecedented suitability for the study of tumour initiation and early 
progression.  As such, a variety of studies using zebrafish as a model organism 
have uncovered important mechanisms of  early tumour development  in 
different types of cancer, including melanoma [154,170,171], hepatocellular 
carcinoma (HCC) [160,172], pancreatic adenocarcinoma [173,174] and glioma 
[149]. 
The epidermis of the developing zebrafish comprises a periderm of terminally 
differentiated keratinocytes and a basal layer with both differentiated 
keratinocytes and epidermal stem cells sitting on a basement membrane, 
much like the mammalian embryonic epidermis [175–178]. While zebrafish 
larval skin is structurally different from mammalian adult epidermis, the 
identification of zebrafish orthologues for mammalian keratinocyte stem cell 
specific markers (tp63) and for keratin isoforms suggests there is genetic 
conservation between the zebrafish and mammals [179–181]. The 
establishment of this structure as the main organ for gas exchange coupled 
with the differentiation of specialized cell types for ion transport and mucous 
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secretion confer the larval skin epidermis morphological and functional 
similarities with other mammalian epithelial structures such as lung, prostate, 
mammary gland, colon and kidney [176,178,182,183]. Therefore, findings 
obtained from the study of zebrafish larval skin can also be loosely 
extrapolated to the mechanisms of tumour initiation in epithelial tissues coating 
mammalian internal organs, which are inaccessible to high resolution in vivo 
studies. 
 
1.9 Zebrafish as a Model Organism for the Study of Inflammation and 
Neutrophil Biology         
 
Fish immunology has long been a subject of scientific inquiry. From an 
evolutionary perspective, fish comprise a relevant comparative outgroup to 
understand the evolution of vertebrate immune systems [184]. Furthermore, 
the increasing understanding of fish immune systems and their multiple 
similarities to mammalian systems has propelled the use of teleost model 
organisms, namely zebrafish, for the study of disease processes such as 
infection and cancer [185].  
The inflammatory response is the primary manifestation of the innate immune 
system. Given their predominant abundance in circulation and their immediate 
mobilization to sites of infection and tissue damage, neutrophils are considered 
central effectors of inflammation.  
Zebrafish neutrophils, also known as heterophil granulocytes, are detected for 
the first time in the developing larva at 33 hpf. By 48 hpf neutrophils are fully 
functional and constitute the majority of the zebrafish larva leucocyte 
population [186,187]. Similarly to mammalian neutrophils, these granulocytes 
contain primary and secondary granules and high levels of myeloid specific 
peroxidase [187]. Zebrafish neutrophils also share several biochemical and 
functional features with mammalian neutrophils. Namely, they are capable of 
phagocyte and consequently kill bacteria [188]. Their antimicrobial activity is 
also evident by their ability to generate NADPH oxidase-dependent oxidative 
stress [189] and to release neutrophil extracellular traps (NETs) [190]. 
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At the molecular level, zebrafish innate immunity exhibit a higher level of 
complexity than mammalian systems. Key inflammatory factors such as TLRs, 
MyD88 and other adaptor proteins, and transcription factors involved in the 
NF-kB signalling pathway, are highly conserved. Conversely, other 
components of zebrafish innate immunity, namely, complement system, 
pattern recognition receptors and some cytokines, have been through 
significant expansion and consequent phylogenetic divergence from other 
vertebrates [191–195]. The increased molecular complexity of zebrafish innate 
immunity allows for increased functional flexibility and redundancy, which may 
be important for efficient protection against exposure to microorganisms 
before adaptive immunity is fully functional [184]. 
Given the late maturation of zebrafish adaptive immune system, which is not 
complete until approximately three weeks post fertilization [196], zebrafish 
larval stages are specially suitable for the study of the direct role of innate 
immunity and inflammation in disease progression, providing a window in 
which the innate immunity can be studied in the absence of T and B cell 
responses. These studies are facilitated by the availability of various tissue 
specific fluorescent reporter transgenic lines, labelling distinct innate immune 
cell populations, namely, neutrophils [197–199] and macrophages [200,201], 
which allow for high resolution in vivo observations of these inflammatory cells’ 





1.10 Hypothesis and Aims of the Project 
 
While it has been established inflammation is an important component of a 
tumour microenvironment, the role of specific regulatory pathways has shown 
to be extremely complex with context dependent effects. Due to the limited 
available tools that allow the study of early stages of tumour development, the 
role of the inflammatory mechanisms during that stage are even more elusive. 
The hypothesis for this project is that MyD88-NF-κB dependent signalling is 
involved in the mechanisms that support the pre-neoplastic cell induced 
inflammation and early tumour development. 
 
The aims of the project are to: 
 
• Develop and characterize a model for conditional generation of pre-
neoplastic epithelial cell in the basal skin cell layer of the larval 
zebrafish. 
 
• Characterize the inflammatory response induced by pre-neoplastic 
cells. 
 
• Assess the role of MyD88-NF-kB for the establishment of the 
neutrophilic inflammatory response. 
 
• Establish the cell specific role of MyD88-NF-kB signalling in pre-
neoplastic cell progression.  
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2 Materials and Methods 
 
2.1 Media and Solutions 
 
All reagents were acquired from Sigma-Aldrich, unless otherwise stated. 
 
Embryo Medium 




0.1% Methylene Blue 
 




0.6mM Ca(NO3)2  
5.0mM HEPES   Adjust pH to 7.6 
 
Induction Solution 
0.3x Danieau’s Solution 
0.5%(v/v) DMSO 




5G Yeast Extract 
5G NaCl 
1ML 1M NaOH  




 LB Broth 














0.5%(v/v) Triton X-100 
 
Calcium-free Ringers Solution 
5mM HEPES  
2.9mM KCl  
116mM NaCl  
 
TAE (10x) 
 48.4G Tris 
3.7G EDTA 
11.4ML Acetic Acid 




2.2 Expression Constructs Generation 
 
Expression constructs were generated according to the Tol2kit [202] using 
MultiSite Gateway Three-Fragment Vector Construction Kit (Invitrogen, 
12537-023). All reagents and plasmids were acquired from Invitrogen, unless 
otherwise stated.  
For generation of DNA fragments of interest, PCR was performed using 
primers as depicted in Table 2.1. pTol2-5xUAS:mCherry-HRasG12V, kindly 
provided by Masazumi Tada (University College London, UK), was used as 
DNA template. PCR reaction was set up as stated in Table 2.2 and run in a 
Mastercycler Nexus Gradient GSX1 Thermal Cycler (Eppendorf) according to 
Table 2.3. 
PCR products were purified using the DNA Clean & Concentrator™ Kit (Zymo 
Research, D4003) according to manufacturer’s instructions. To generate pME 
vectors, equimolar amounts of attB PCR product and pDONR 221 vector were 
mixed in TE Buffer with 2µL BP Clonase II Enzyme Mix in a total volume of 
10µL. To generate expression constructs, equimolar amounts of destination 
vector, and 5’, middle and 3’ entry vectors (Table 2.4) were combined in TE 
Buffer with 2µL LR Clonase II Plus Enzyme Mix in a total volume of 10µL.  
Following an over-night incubation at 25°C, enzyme was degraded in a 10-min 
incubation at 37°C after addition of 1 µL of Proteinase K solution (2µg/µL). 





Table 2.1 Primer sequences used for PCR amplification of insert of 
interest for Multisite Gateway cloning 
 


























Table 2.2 PCR reaction mix for amplification of DNA fragment of interest 
for Multisite Gateway cloning 
 
5x Q5 Reaction Buffer (New England Biolabs) 10 µL 
10mM dNTPs (Roche) 1 µL 
10µM Fw Primer 1 µL 
10µM Rv Primer 1 µL 
DNA Template 50-100 ng 
Q5 High-Fidelity DNA Polymerase (New 
England Biolabs) 
0.5 µL 
Nuclease Free Water To 50 µL 
 
 
Table 2.3 PCR cycling conditions for amplification of insert of interest for 
Multisite Gateway cloning 
 
Step Temperature Duration Cycles 
Initial Denaturation 95°C 2 min  
Denaturation 95°C 30 sec 30 
cycles Annealing Primer Optimised 30 sec 
Extension 72°C 2 min 
Final Extension 72°C 7 min  




Table 2.4 Entry vectors used for generation of expression constructs 
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p5’E: 6xUAS pME: 
mCherry-
CAAX 
p3’E: polyA pDestTol2CG2 
 
 
2.3 Bacterial Transformation and Plasmid Purification  
 
All imported and newly generated plasmids went through bacterial 
transformation for plasmid propagation. All reagents were acquired from 
Invitrogen, unless otherwise stated. One Shot™ ccdB Survival™ 2 T1R 
Competent Cells were used for transformation with empty vectors. One Shot 
TOP10 chemically competent E. coli were transformed with remaining 
plasmids. Frozen bacteria vials were thawed on ice. 1-4 µL of plasmid were 
carefully added to the vial and gently mixed. After a 30 min incubation on ice 
cells were heat-shocked at 42°C for 30 seconds, immediately followed by a 2 
min incubation on ice. 250 µL of S.O.C. medium was then added and vials 
were incubated at 37 °C, 200 rpm for 1 hour. Transformed bacteria were plated 
in the appropriate antibiotics selective LB agar plates and incubated at 37°C 
over-night. Individual, isolated colonies were picked and grown in selective LB 
Broth with the appropriate antibiotics at 37 °C, 200 rpm over-night. Following 
bacterial growth in LB selective medium, plasmids were purified with Qiagen 
Plasmid Purification Kits according to manufacturer’s instructions. For 
sequencing, diagnostic digests and cloning purposes, a 5mL culture volume 
was used and processed with the QIAprep Spin Miniprep Kit. For high purity, 
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larger volumes of plasmids necessary for microinjections, 25-50 mL culture 
volume was used and processed with the QIAGEN Plasmid Midi Kit. Plasmid 
DNA concentration was measured using NANODROP™ 1000 
spectrophotometer. Integrity of all purified plasmids was verified by restriction 
digestion. Following 2h incubation with appropriate restriction enzyme (New 
England Biolabs) and respective buffer at the temperature for optimal 
enzymatic activity, digested plasmids were mixed with gel loading dye (New 
England Biolabs) and run on an agarose gel (1-1.6% (w/v) agarose, 1xTAE) 
electrophoresis with a PowerPac™ Basic Power Supply (BioRad) at 100V with 
1xTAE as conductive buffer. PCR amplified inserts were further verified by 
sequencing analysis of entry vectors with M13 Forward and T7 Reverse 
primers using the Mix2seq service from Eurofins Genomics. Predicted 
sequences of each plasmid were generated in Ape – A plasmid Editor (version 
2.0.51) and analysed in SnapGene Viewer (version 4.1). 
 
2.4 Transposase mRNA Synthesis 
 
Transposase mRNA was synthesised using pT3TS/Tol2 plasmid [203] as a 
template. Plasmid DNA was linearized with BamHI (New England Biolabs, 
R0136S) and purified with DNA Clean & Concentrator kit (Zymo Research, 
D4033) according to the manufacturer’s instructions. Capped mRNA in vitro 
transcription was performed using the mMessage mMachine T3 Transcription 
Kit (Invitrogen, AM1348) according to the manufacturer’s instructions. 1µg of 
linearized plasmid was mixed with 1x reaction buffer, 1x NTP/CAP mix and 2 
µL of T3 enzyme mix in a 20 µL reaction solution and incubated for 2 hours at 
37oC. The DNA template was then degraded in a 15-min incubation at 37oC 
after addition of 1 µL of TURBO DNase (2U/µL). Transcribed RNA was 
recovered by Lithium Chloride precipitation in which RNA was kept in a 18 mM 
EDTA, 2.5 M Lithium Chloride solution at -20oC for 1 hour and pelleted by 
centrifugation at 4 °C, 14000rpm for 15 minutes. Pellet was then washed with 
70% Ethanol and re-centrifuged with the same parameters. After removal of 
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70% Ethanol, pellet was air-dried for 5 minutes and resuspended in Nuclease-
Free Water (Invitrogen, AM9930). 
 
2.5 Zebrafish Husbandry 
 
Adult zebrafish (Danio rerio) were maintained and handled following previously 
described protocols [204] and in accordance with the UK Home Office 
Regulations. Wild-type zebrafish of the Tuebingen (TUE) strain, maintained by 
the CBS Aquatics Facility at The University of Edinburgh, were used, unless 
otherwise stated. Transgenic zebrafish lines used throughout the project 
(Table 2.5) were maintained under Home Office license held by Dr. Yi Feng.  
Fertilized zebrafish eggs were collected, washed and transferred to fresh 
embryo medium. Eggs were checked for viability and staged according to time 
post fertilization [205]. Embryos were maintained for up to 5 dpf at 28.5oC. For 
screening purposes, embryos were kept under anaesthesia with embryo 
medium containing 0.02% buffered 3-aminobenzoic acid ethyl ester 
(Tricaine/MS-222). Desired phenotype was detected using a Leica M205 FA 
Fluorescence Stereo Microscope. 
 
Table 2.5 Zebrafish transgenic lines used throughout the project 
 
Transgenic Zebrafish  Line Reference 
Tg(krtt1c19e:KalTA4-ERT2) Unpublished, generated in Paul Martin’s 
Laboratory with construct generated in 
the Feng Laboratory (Supplementary 
Figure 1) 
Tg(krt4:KalTA4-ERT2) Unpublished, generated in Paul Martin’s 
Laboratory with construct generated in 




Tg(UAS:IkBSR) Unpublished, generated by Yi Feng in 
Paul Martin’s Laboratory 
Tg(lyz:IkBSR) Unpublished, generated by Nikolay 
Ogryzko in the Feng Laboratory 
Tg(lyz:DsRed2)nz50 [198] 
























2.6 Generation of Transgenic Zebrafish 
 
2.6.1 Microinjection of Zebrafish Eggs 
 
Adult zebrafish were set up in pair mating tanks overnight. To avoid premature 
mating, male and female zebrafish were kept separated by dividers. The 
following morning dividers were lifted to allow mating. Fertilized eggs were 
immediately collected and aligned on a plate, against a slide. Microinjections 
were performed using a borosilicate glass capillary needle (World Precision 
Instruments 1B100F-4) connected to a Pico-Liter Injector (Warner 
Instruments, PLI-90A). One-cell-stage embryos were co-injected into the 
blastodisc with 7.5 pg of plasmid DNA and 40 pg of capped Tol2 transposase 
mRNA in a volume of 0.5 nL 1X Danieau’s solution. DNA constructs used for 
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microinjection throughout the project are listed in Table 2.6. Injected eggs were 
incubated as previously described. 
 
Table 2.6 Constructs used for microinjection throughout the project 
 
Construct Origin 
UAS:eGFP-HRasG12V Generated by Thomas Ramezani in the Feng 
Laboratory 
UAS:eGFP-CAAX Generated by Lisa Kelly in the Feng 
Laboratory 
UAS:mCherry-HRasG12V Generated during this project 
UAS:mCherry-CAAX Generated during this project 




2.6.2 Generation of Transgenic Stable Lines 
 
Wilde-type adult zebrafish were mated and fertilized eggs were injected with 
lyz:lifeact-mTurquoise2a DNA construct (Supplementary Figure 2) as 
previously described. 3dpf injected larvae were screened for mTurquoise 
expression in neutrophils and selected larvae were raised to adulthood. Once 
zebrafish reached sexual maturity they were crossed with Wild-type for 
identification of founder fish with germ line integration and stable transmission 
to their offspring. Two founders  were identified and larvae with transgene 
expression were raised to adulthood constituting F1 generation. Stable 
transgenic line was established based on the F2 generation with the strongest 
reporter gene expression. 
Double transgenic lines were generated through line crosses. Male and female 
adult zebrafish from each transgenic line were set up in pair mating tanks 
overnight and eggs were collected the following morning. 3dpf larvae were 
screened and selected double positive larvae were raised to adulthood. 
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2.6.3 Generation of Zebrafish Larvae with Transient KalTA4-ERT2/UAS 
Mediated Gene Expression 
 
KalTA4-ERT2 transgene carrier adult zebrafish were mated according to 
experimental requirements and fertilized eggs were injected with DNA 
constructs containing UAS driven transgene (Supplementary Figure 3), as 
previously described. Injected embryos were screened at 2dpf for desired 
phenotype and selected embryos were transferred to induction solution and 
kept in the dark for the duration of the experiment. When appropriate, embryos 
were screened and selected for desired proportion of HRasG12V/CAAX 
expressing cells. Embryos were transferred into fresh induction solution every 
24 hours. 
 
2.7 Drug Treatment 
 
Embryos were screened at 7hpi and treated with 5 µM Trametinib 
(Selleckchem, S2673) or 0.5% (v/v) DMSO by immersion at 28.5 °C for 
specified time intervals, determined by experimental requirements. 
 
2.8 Live Image Acquisition and Analysis 
 
For all live imaging studies, larvae were mounted on lateral view in 1% low 
melting point agarose (LMP) (Invitrogen, 16520-050) in 0.3x Danieau’s 
solution, in a glass-bottomed dish, filled with induction solution containing 
0.02% Tricaine. Screening and full body imaging was performed under a Leica 
M205 FA Fluorescence Stereo Microscope. Detailed images were taken using  
confocal microscopy as specified below and, when necessary, analysed with 






2.8.1 Characterization of Cell Morphology 
 
Tg(krtt1c19e:KalTA4-ERT2) adult zebrafish were in crossed and fertilized eggs 
were injected with UAS:eGFP-HRasG12V or UAS:eGFP-CAAX followed by 
induction as described previously. Larvae were screened at appropriate time-
points for eGFP (PNCs/CAAX cells) expression. A selected subset from each 
group were mounted as described above. Images were taken on a Zeiss LSM-
780 inverted confocal laser scanning microscope with a 40x oil immersion 
objective lens using the 488nm laser. Zen 2011 software was used for image 
collection. Aggregates of eGFP positive cells were categorised according to 
cell shape. 
 
2.8.2 Analysis of NF-kB Activity in PNCs  
 
Tg(krt4:KalTA4-ERT2); Tg(NFkB:eGFP) adult zebrafish were in-crossed  and 
fertilized eggs were injected with UAS:mCherry-HRasG12V or UAS:mCherry-
CAAX followed by induction as described previously. Larvae were screened at 
8hpi for eGFP (NF-kB reporter) and mCherry (PNCs/CAAX cells) expression. 
A selected subset from each group were mounted as described above. Images 
were taken on a Leica TCS SP5 confocal laser scanning microscope attached 
to an inverted DMI 6000 CS microscope base with an HC PLAN APO 20x dry 
objective lens in 30 min intervals for a duration of 14 hours (10-24 hpi) using 
the 488nm and 594 nm lasers.  
For drug treatment experiments, drug was added, when mounting the larvae, 
to mounting media and induction solution. Larvae were kept in mounting media 
during drug treatment, in between image collection time-points. Images were 
taken on a Leica TCS SP8 confocal laser scanning attached to an inverted, 
motorised DMi8 research microscope base with a HC PL APO 20x CS2 dry 
objective lens at 9hpi and 18hpi using the 488nm and 596 nm lasers. Leica 
Application Suite Advance Fluorescence (LAS AF) software was used for 
image collection in both experiments. 
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Time-lapse videos and images were analysed with the image analysis 
software IMARIS (version 9.2.1) as follow. HRasG12V/CAAX positive cells were 
isolated using the Surfaces module based on absolute mCherry intensity and 
eGFP mean intensity within each Surface was measured. eGFP mean 
intensity in the lateral line was calculated with the Spots module. When 
needed, analysis was restricted to areas of interest for efficient separation of 
HRasG12V/CAAX positive cells from lateral line and neuromasts, which exhibit 
constitutive eGFP (NF-kB reporter) expression. To account for variation due 
to differences in transgene copy number mean intensity values within each 
larva were normalized to eGFP expression level in the lateral line at the earliest 
time-point. Fold Change was calculated as the ratio between eGFP mean 
intensity at 24hpi and 10hpi. Quantification of eGFP/mCherry double positive 
cells at 10hpi and 24hpi was performed manually by optical sectioning, 
whereby each slice within a z-stack was individually analysed to assure the 
correct assessment of cells in distinct focal planes. 
 
2.8.3 Analysis of myd88 Gene Expression in PNCs 
 
Tg(krtt1c19e:KalTA4-ERT2); Tg(myd88:DsRed2) adult zebrafish were in-
crossed and fertilized eggs were injected with UAS:eGFP-HRasG12V or 
UAS:eGFP-CAAX followed by induction as described previously. Larvae were 
screened at appropriate time-points for DsRed (myd88 gene reporter) and 
eGFP (PNCs/CAAX cells) expression. A selected subset from each group 
were mounted as described above. Images were taken on a Zeiss LSM-780 
inverted confocal laser scanning microscope with a 40x oil immersion objective 
lens at 12hpi, 24 hpi, 36hpi and 48hpi using the 488nm and 561nm lasers. Zen 
2011 software was used for image collection. Each larva was imaged in up to 
three different areas of the trunk. 
Images were analysed with the image analysis software IMARIS (version 
9.2.1) as follow. Quantification of DsRed/eGFP double positive cells at 
different time-points was performed manually by optical sectioning. 
HRasG12V/CAAX positive cells were isolated using the Surfaces module based 
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on absolute eGFP intensity. The Distance Transformation XTension allowed 
for the generation of an additional channel where intensity translated the 
distance to HRasG12V/CAAX generated Surfaces. Neighbouring Cells were 
isolated using the Surfaces module based on the Distance Transformation 
Channel  with a 25 intensity value as the top threshold. This allowed the 
generation of 25 µm wide surfaces surrounding the HRasG12V/CAAX positive 
cells. DsRed mean intensity within each Surface was measured at different 
time-points. 
 
2.8.4 Analysis of NF-kB Activity in Neutrophils 
 
Tg(krt4:KalTA4-ERT2); Tg(NFkB:eGFP) adult zebrafish were out-crossed to 
Tg(lyz:DsRed2) adult zebrafish and fertilized eggs were injected with 
UAS:eGFP-HRasG12V followed by induction as described previously. Larvae 
were screened at 22hpi for DsRed (neutrophils) eGFP (PNCs/CAAX cells; NF-
kB reporter) expression. A selected subset were mounted as described above. 
Images were taken on a Leica TCS SP5 confocal laser scanning attached to 
a DMI 6000 CS inverted microscope with a HC PLAN APO 20x dry objective 
lens in 1 min 30 sec intervals for a duration of 2 hours (24-26 hpi) using the 
488nm and 543nm lasers. Leica Application Suite Advance Fluorescence 
(LAS AF) software was used for image collection.  
Time-lapse videos were analysed with the image analysis software IMARIS 
(version 9.2.1) as follow. Neutrophils were isolated using the Surfaces module 
based on absolute DsRed intensity and tracked using a Brownian movement 
based algorithm. Cell tracking was manually checked and corrected when 
necessary. When more than one neutrophil converged into the same surface, 
the latter was cut at the appropriate intersection planes and tracks were 
rearranged  accordingly. Individual neutrophils were analysed according to 




2.8.5 Neutrophil Recruitment 
 
Tg(krtt1c19e:KalTA4-ERT2); Tg(lyz:DsRed2) adult zebrafish were in-crossed 
and fertilized eggs were injected with UAS:eGFP-HRasG12V or UAS:eGFP-
CAAX followed by induction as described previously. Larvae were screened at 
10hpi for DsRed (neutrophils) and eGFP (PNCs/CAAX cells) expression. A 
selected subset from each group were mounted as described above. Images 
were taken on a Leica TCS SP8 confocal laser scanning attached to an 
inverted, motorised DMi8 research microscope base with a HC PL APO 20x 
CS2 dry objective lens in 15 min intervals for a duration of 24 hours (12-36 hpi) 
using the 488nm and 561nm lasers. Leica Application Suite Advance 
Fluorescence (LAS AF) software was used for image collection. Neutrophils 
within the skin were manually counted at each frame using the Spots module 
of the image analysis software IMARIS (version 9.2.1).  
 
2.8.6 Analysis of Neutrophil Behaviour in krtt1c19e:IkBSR Background 
 
Tg(krtt1c19e:KalTA4-ERT2); Tg(lyz:DsRed2) adult zebrafish were out-crossed 
to  Tg(UAS:IkBSR) adult zebrafish and fertilized eggs were injected with 
UAS:eGFP-HRasG12V followed by induction as described previously. Larvae 
were screened at 20hpi for DsRed (neutrophils) and eGFP (PNCs) expression. 
The presence/absence of red-fluorescent marker “bleeding heart” (BH, 
cmlc2:mCherry) was used to differentiate krtt1c19e:IkBSR from WT larvae. A 
selected subset from each group were mounted as described above. Images 
were taken on a Leica TCS SP8 confocal laser scanning attached to an 
inverted, motorised DMi8 research microscope base with a HC PL APO 20x 
CS2 dry objective lens in 1 min 30 sec intervals for a duration of 3 hours (22-
25 hpi) using the 488nm and 561nm lasers. Leica Application Suite Advance 
Fluorescence (LAS AF) software was used for image collection. 
Time-lapse videos were analysed with the image analysis software IMARIS 
(version 9.2.1) as follow. Neutrophils were isolated using the Surfaces module 
based on absolute DsRed intensity and tracked using a Brownian movement 
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based algorithm. Cell tracking was manually checked and corrected when 
necessary. When more than one neutrophil converged into the same surface, 
the latter was cut at the appropriate intersection planes and tracks were 
rearranged  accordingly. HRasG12V positive cells were isolated using the 
Surfaces module based on absolute eGFP intensity. The Distance 
Transformation XTension allowed for the generation of an additional channel 
where intensity translated the distance to HRasG12V generated Surfaces. 
Neutrophil tracks were only considered from the time-point they were first in 
contact with a HRasG12V positive cell forward. Neutrophil surfaces were 
analysed according to the following module featured parameters: Track Mean 
Speed, Track Distance Channel Mean Intensity corresponding to Track 
Distance to PNCs and Track Straightness. Retention Time was calculated 
manually as the maximum uninterrupted period of time spent “visiting” a 
specific PNC aggregate. 
 
2.8.7 Analysis of myd88 Gene Expression and Behaviour Diversity of 
Recruited Neutrophils 
 
Tg(krtt1c19e:KalTA4-ERT2); Tg(myd88:DsRed2) adult zebrafish were out-
crossed to Tg(krtt1c19e:KalTA4-ERT2); Tg(lyz:lifeact-mTurquoise2a) adult 
zebrafish and fertilized eggs were injected with UAS:eGFP-HRasG12V or 
UAS:eGFP-CAAX followed by induction as described previously. Larvae were 
screened at 22hpi for DsRed (myd88 gene reporter), eGFP (PNCs/CAAX 
cells) and mTurquoise (neutrophils) expression. A selected subset from each 
group were mounted as described above. Images were taken on a Zeiss LSM-
780 inverted confocal laser scanning microscope with a 20x dry objective lens 
in 2 min intervals for a duration of 2 hours (24-26 hpi) using the 405nm, 488nm 
and 561nm lasers. Zen 2011 software was used for image collection. 
Time-lapse videos were analysed with the image analysis software IMARIS 
(version 9.2.1) as follow. Neutrophils were isolated using the Surfaces module 
based on absolute mTurquoise intensity or absolute DsRed intensity 
depending on which parameter allowed for a more accurate representation of 
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the full body of each individual neutrophil. Resulting surfaces were tracked 
using a Brownian movement based algorithm. Cell tracking was manually 
checked and corrected when necessary. When more than one neutrophil 
converged into the same surface, the latter was cut at the appropriate 
intersection planes and tracks were rearranged  accordingly. Neutrophil 
surfaces were analysed according to mTurquoise mean intensity and DsRed 
mean intensity. To account for variation due to differences in transgene copy 
number, mean intensity values of each neutrophil were normalized to average 
intensity of all neutrophils within each larva. Relative DsRed average intensity 
(=1) was used as an arbitrary value to segregate the two neutrophil subsets 
compared in the subsequent analysis of migratory behaviour. Neutrophil 
Speed values were obtain through the Surfaces module inbuilt parameter 
measurements. Retention Time was calculated manually as the maximum 
uninterrupted period of time spent “visiting” a specific PNC aggregate and used 
to restrict Neutrophil Speed values to be considered. 
 
2.9 Fluorescent Staining 
 
2.9.1 EdU Labelling 
 
Cell proliferation was assessed using the Click-iT™ Plus EdU Alexa Fluor™ 
647 Imaging Kit (Life Technologies, C10640). Unless otherwise stated, all 
washes and incubation steps were carried out at room temperature with light 
shaking (60-65 rpm). Larvae were screened at appropriate time-points. 
Selected larvae were injected into the yolk with 0.5nL of 10mM EdU (5-ethynyl-
2'-deoxyuridine, a nucleoside analogue of thymidine) and incubated for 2.5 
hours at 28.5oC. After a 30-min over the bench incubation in fixative solution, 
larvae were permeabilized in PBS containing 0.5% Triton X-100 (PBST) four 
times for 5 min and blocked with PBST containing 3% (w/v) Bovine Serum 
Albumin for 1 hour at room temperature. Larvae were then transferred to the 
Click-it Plus reaction cocktail (1xClick-iT Plus EdU reaction buffer, copper 
protectant, Alexa Fluor 647 picolyl azide dye, reaction buffer additive), made 
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as per manufacturer’s instructions, incubated for 30 min protected from light 
and later subjected to whole-mount immunofluorescence staining as described 
below. 
 
2.9.2 TUNEL Labelling 
 
Cell death was assessed using the Click-iT™ Plus TUNEL Assay for In Situ 
Apoptosis Detection Alexa Fluor™ 647 Imaging Kit (Life Technologies, 
C10617). Unless otherwise stated, all washes and incubation steps were 
carried out at room temperature with light shaking (60-65 rpm). Larvae were 
transferred to fixative solution and incubated for 2 hours over the bench. 
Following extensive washing steps in PBST, larvae were permeabilized with 
10 µg/mL Proteinase K in PBST. The duration of the treatment was dependent 
on their developmental stage: 3 min treatment for 3dpf (24hpi) larvae and 4 
min treatment for 3.5dpf (36hpi) larvae. Larvae were then immediately rinsed 
twice in PBST and re-fixed for 20 min. After 4 consecutive 5-min washes with 
PBST, larvae were incubated in TdT reaction buffer for 10 min at 37oC. Larvae 
were, then, transferred to TdT reaction mix (TdT reaction buffer, EdUTP, TdT 
enzyme), made as per manufacturer’s instructions, and incubated for 1h at 
37oC. Following an 1-hour incubation in PBST containing 3% (w/v) Bovine 
Serum Albumin blocking solution, larvae were transferred to the Click-it Plus 
TUNEL reaction cocktail (1x Click-iT Plus TUNEL reaction buffer, copper 
protectant, Alexa Fluor 647 picolyl azide dye, Click-iT Plus TUNEL reaction 
buffer additive), made as per manufacturer’s instructions, incubated for 30 min 
at 37oC protected from light and later subjected to whole-mount 
immunofluorescence staining as described below. 
 
2.9.3 Whole Mount Immunofluorescence Staining 
 
Unless otherwise stated, all washes and incubation steps were carried out at 
room temperature with light shaking (60-65 rpm). Larvae were washed in 
PBST 3 times for 15 min and blocked with PBST containing 10% (v/v) goat 
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serum, 3% (w/v) Bovine Serum Albumin for 2 hours at room temperature, 
before an over-night incubation at 4oC with primary antibody in blocking 
solution. Primary antibodies used through the course of this project include 
rabbit monoclonal anti-GFP (1:200) (Cell Signalling Technology, 2956) and 
mouse monoclonal anti-RAS (1:200) (BD Biosciences, 610001). After ten 15-
min PBST washes, larvae were incubated with secondary antibody in blocking 
solution for 2 hours. Secondary antibodies used through the course of this 
project include Alexa Fluor 488 Goat anti-Rabbit IgG (H+L) (1:250) (A-11008, 
Invitrogen) and  Alexa Fluor 488 Goat anti-Mouse  IgG (H+L) (1:250) (A-11001, 
Invitrogen). Larvae were then washed in PBST 10 times and subjected to a 
gradient of decreasing concentrations of PBS and increasing concentrations 
of glycerol to be stored in a glycerol based antifading mounting medium 
(CitiFluor, AF1) at 4oC. 
 
2.9.4 Confocal Image Acquisition and Analysis 
 
Stained larvae were mounted, on lateral view, in the glycerol based antifading 
mounting medium on a slide and coverslip. Images were taken on a Leica TCS 
SP8 confocal laser scanning attached to an inverted, motorised DMi8 research 
microscope base with a HC PL APO 40x CS2 oil immersion objective lens 
using 488nm and 633nm lasers. Leica Application Suite Advance 
Fluorescence (LAS AF) software was used for image collection. 
Images were analysed with the image analysis software IMARIS (version 
9.2.1) as follow. Quantification of proliferating HRasG12V/CAAX positive cells 
was performed manually by optical sectioning. For quantification of 
proliferating neighbouring cells, the remaining EdU positive nuclei, not within 
eGFP positive cells, were manually selected using the Spots module. 
HRasG12V/CAAX positive cells were isolated using the Surfaces module based 
on absolute GFP intensity. The Spots Close To Surface XTension allowed 
segregation of the spots subset within 10 µm distance to the nearest point of 
the Surface objects. Proliferating neighbouring cells are shown as a proportion 
of the number of spots in that subset to the number of HRasG12V/CAAX positive 
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cells. Quantification of dying cells HRasG12V/CAAX positive cells was 
performed manually by optical sectioning from TUNEL labelling images. 
 
2.10 Larvae Dissociation and Flow Cytometry Analysis 
 
Larvae were screened at the appropriate time-point for eGFP (PNCs/CAAX 
cells) expression as well as the presence of the required reporter genes 
(neutrophil lineage specific transgenic line and either myd88 or NF-kB reporter 
lines). Multiple larvae with the desired phenotype (35-40 larvae per group) 
were transferred to calcium-free Ringers solution and incubated at 4oC for 15 
min. After two rinses in calcium-free Ringers solution, larvae were transferred 
to dissociation solution (Calcium-free Ringers solution, 2mM CaCl2, 0.25% 
Collagenase D (Gibco)) and incubated at 28.5oC with shaking (100 rpm), 
during which additional mechanical dissociation was achieved with vigorous 
pipetting in 5-min intervals. Full  dissociation was regularly achieved within 30 
minutes and resulting cells were pelleted by centrifugation at 3000 rpm for 3 
minutes at 4oC. Pellet was then washed twice with PBS and re-centrifuged 
each time with the same parameters. Pellet was resuspended in 750 μL PBS 
and filtered using a 40 μm Corning cell strainer to obtain a single cell 
suspension.  
Flow cytometry was performed with a BD 5 laser LSR Fortessa cell analyser.  
mTurquoise positive cells were detected with V450/50-A laser. B525/50-A 
laser was used to detect eGFP positive cells.YG582/15-A laser was used to 
detect DsRed positive cells. B670/30-A laser was used to exclude 
autofluorescence. Single cell suspensions from WT and single transgenic 
larvae were equally obtained and analysed to establish appropriate 
compensation and gating strategy (Supplementary Figures 4 and 5). For 
compensation and gating strategy set up, a minimum of 100.000 total events 
were analysed per sample. For data acquisition, a minimum of 1000 events for 
the neutrophil population were analysed per sample.   
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2.11 Gene Expression Analysis 
 
2.11.1 RNA Extraction and cDNA Synthesis 
 
Larvae were screened at the appropriate time-point. Multiple larvae with the 
desired phenotype (40-50 larvae per group) were transferred to 500 μL TRIzol 
reagent (Invitrogen) to preserve RNA integrity. Following an over-night 
incubation at -80oC, samples were thawed and homogenized by repeatedly 
passing through a  23 gauge needle (BD Microlance) with the help of a 1 mL 
syringe (BD Plastipak) and vigorous vortexing. Total RNA was isolated with 
chloroform extraction followed by isopropanol precipitation. After a 1-hour 
incubation at -20oC to allow full RNA precipitation, RNA was pelleted by 
centrifugation at 4 °C, 14000rpm for 15 minutes. Pellet was then washed with 
70% Ethanol and re-centrifuged with the same parameters. After removal of 
70% Ethanol, pellet was air-dried for 5 minutes and resuspended in Nuclease-
Free Water (Invitrogen, AM9930). 
cDNA synthesis was achieved using the iScript™ Advanced cDNA synthesis 
Kit for RT-qPCR (Bio Rad, 1725037). As per manufacturer’s instructions, 4 μL 
5x iScript Advanced Reaction Mix and 1 μL iScript Advanced Reverse 
Transcriptase were added to 15 μL isolated RNA. Resulting reaction mixture 
was incubated at 46°C for 20 minutes and then at 95 °C for 1 minute, in a 
Mastercycler Nexus Gradient GSX1 Thermal Cycler (Eppendorf). cDNA was 
stored at -20°C. 
 
2.11.2 Quantitative RT-PCR 
 
For qRT-PCR reaction set up, cDNA was mixed with PowerUp™ SYBR™ 
Green Master Mix (Applied Biosystems, A25742) and loaded into a 
MicroAmp® EnduraPlate™ Optical 96-well Fast Clear Reaction Plate (Applied 
Biosciences, 4483485). The appropriate primers (Table 2.7) were also loaded 
into the plate at a final concentration of 500nM in a total reaction volume of 10 
μL per well. qRT-PCR was performed using a StepOnePlusTM Real-Time PCR 
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System (Applied Biosystems) according to the protocol shown in Table 2.8 and 
results were analysed with StepOne Software (version 2.3). 
 
Table 2.7 Primer sequences used for qRT-PCR 
 
Gene Primers 
rps11 Fw: 5’-ACAGAAATGCCCCTTCACTG-3’ 
Rv: 5’-GCCTCTTCTCAAAACGGTTG-3’ 
gapdh Fw: 5’-GTGGAGTCTACTGGTGTCTTC-3’ 
Rv: 5’-GTGCAGGAGGCATTGCTTACA-3’ 
mmp9 Fw: 5’-CATTAAAGATGCCCTGATGTATCCC-3’ 
Rv: 5’-AGTGGTGGTCCGTGGTTGAG-3’ 
il-1 Fw: 5’-GAACAGAATGAAGCACATCAAACC-3’  
Rv: 5’-ACGGCACTGAATCCACCAC-3’ 
cxcl8 Fw: 5’-TGTGTTATTGTTTTCCTGGCATTTC-3’  
Rv: 5’-GCGACAGCGTGGATCTACAG-3’ 





Table 2.8 qRT-PCR cycling conditions for analysis of gene expression 
 
Step Temperature Duration Cycles 
UDG activation 50°C 2 min Hold 
Dual-LockTM DNA polymerase 95°C  
2 min 
Hold 
Denature 95°C 3 sec 40 






2.12 Statistical Analysis 
 
All graphs were generated using GraphPad Prism 8 for macOS (version 8.0.0).  
Graphs are shown as the mean +/- standard error of the mean (SEM) of all the 
individual data from repeated experiments as indicated in the figure legend. 
Statistical analysis was done using GraphPad Prism 8 for macOS (version 
8.0.0) as described in the corresponding figures. Significance values: *p≤ 0.05, 




3 Overexpression of the HRasG12V Oncogene Promotes the 




Tumorigenesis consists of a stepwise process by which somatic cells acquire 
an increasing number of mutations in oncogenes or tumour suppressor genes, 
giving them an uncontrolled proliferative capacity and invasive properties.   
Despite the well characterised mechanisms whereby mutations in these genes 
potentiate tumour malignancy, only a few oncogenes are capable of 
unleashing clonal expansion of pre-neoplastic lesions, an important step in the 
process of tumour initiation. In fact, cancer related genetic and epigenetic 
alterations are often found in single cells and clonal patches of normal skin 
[209,210] and mammary epithelial tissue [211,212]. 
Ras proteins are ubiquitous small GTPases which control regulatory pathways 
important for cell proliferation, differentiation and survival. Gain-of-function 
mutations in the Ras gene family are often found in human cancers. Four 
different isoforms, HRas, NRas KRas4A and KRas4B, compose the Ras 
protein family. Active mutations in each isoform are more frequently found in 
distinct types of malignancies [24]. Amongst these, HRas mutations, 
particularly HRasG12V, even though less frequent in cancer overall, are 
particularly found in skin squamous cell carcinoma and cancer of the urinary 
bladder [24,213,214]. Considering  Val-12 has the lowest GTPase activity 
amongst possible amino acid substitutions at codon 12, HRasG12V has the 
highest transformation potential [215,216]. The association between mutated 
HRas and tumour initiation in vivo was first established by Quintanilla et al., in 
1986. In a ground-breaking study, these researchers showed nearly 100% of 
tumours produced by chemical DMBA/TPA two stage skin carcinogenesis 
exhibited the same mutation in the HRAS gene [217]. They further 
demonstrated that the nature of the activating mutation was specific to the 
initiating agent used [218]. In agreement with this study, other chemical 
carcinogens were also found to consistently induce tumours with recurrent 
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activating mutations in RAS genes [219–221]. Ras mutations have also been 
frequently found in spontaneously arisen benign lesions, placing oncogenic 
Ras as an early event of tumorigenesis [222–225]. Additionally, 
overexpression of oncogenic HRas and KRas in transgenic mice promotes 
hyperplasia and tumour formation, further confirming the potential role of Ras 
oncogenes as initiators of tumorigenesis [213,226–231].  
In addition to the inherent proliferative capacity of pre-neoplastic lesions, a 
permissive microenvironment is a determinant of tumour development. Recent 
studies have revealed that an organized epithelial structure constitutes a 
suppressive environment for tumorigenesis. In these in vitro studies, the 
interaction of transformed cells with neighbouring wildtype (WT) epithelial cells 
triggered mechanisms of cell competition, whereby activation of distinct 
signalling pathways in this interface led to inhibition of clonal expansion or 
elimination of the transformed cells [232–235]. Considering the typical setting 
of the first stages of tumorigenesis, where transformation occurs in one cell or 
group of cells within an epithelial layer, and given the several lines of defence 
developed by complex multicellular organisms to eliminate aberrant cells, it is 
important to understand the mechanisms whereby certain oncogenic 
mutations can capacitate those cells to evade elimination and expand into self-
sustained tumours.  
Most of our knowledge of tumour initiation is gathered from transformed cell 
culture experiments, from which little can be inferred about the role of the 
microenvironment. The use of mouse models to study tumour formation driven 
by oncogene overexpression or tumour suppressor knockdown can give a 
more comprehensive analysis of the mechanisms involved in tumour 
progression. Murine studies are usually executed after a long latency period, 
when neoplastic lesions have already established dominance over their 
wildtype neighbouring cells, consequently missing key stages of tumour 
initiation. Given the shortage of available tools in this field, we embarked on 
the task of developing a new model to allow the study of interactions between 
pre-neoplastic cells and their microenvironment, and the role of these 
interactions in tumour initiation. 
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3.2 Using a KalTA4-ERT2/UAS Mediated Inducible System to Generate 
Mosaic Expression of an Oncogene in the Skin 
 
To better understand the events that lead to tumour initiation, an inducible, 
tissue specific, zebrafish model was developed in collaboration with Thomas 
Ramezani, a post-doctoral fellow in the laboratory. This will allow the temporal 
control of oncogene expression to generate pre-neoplastic cells (PNCs) and 
enable the detection of the first cues that initiate the process of tumour 
development. Zebrafish larval skin, a bilayer of translucent keratinocytes, is a 
relatively simple structure that allows a non-invasive approach for the study of 
epithelial tumour initiation in a controlled microenvironment in the context of a 
complex multicellular organism. Taking advantage of the GAL4/UAS genetic 
system developed in Drosophila and, since then, optimized for use in zebrafish 
model systems [236], we drive the expression of the HRasG12V oncogene using 
the basal skin layer specific promoter krtt1c19e [177]. This system relies on 
the combinatorial effect of two separate elements: the zebrafish optimized 
version of the transcription factor Gal4, KalTA4, expressed in a tissue-specific 
manner, and the Upstream Activating Sequence (UAS) controlling the 
expression of the fluorescent protein fused HRasG12V oncogene (Figure 
3.2.1A). To conditionally induce oncogene expression, KalTA4 has been fused 
to the modified ligand-binding domain of human estrogen receptor α, ERT2, 
which specifically binds to synthetic 4-Hydroxytamoxifen (4-OHT). In the 
absence of 4-OHT the KalTA4-ERT2 is retained in the cytoplasm by heat-shock 
proteins, blocking its transcriptional activity. Upon 4-OHT binding the heat-
shock protein-ERT2 complex dissociates, allowing nuclear translocation of 
KalTA4-ERT2 and subsequent activation of the UAS controlled gene of interest 
[237,238].  
When both components are stably integrated into the zebrafish genome, 
nearly 100% efficiency of expression is achieved [237,238]. The high efficiency 
of this system, however, introduces an obstacle for the study of tumour 
initiation.  According to the clonal evolution of cancer theory [15], confining 
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Figure 3.2.1 Schematic of the mechanism for conditional PNC generation in the basal 
skin layer. A) Tol2 flanked krtt1c19e:KalTA4-ERT2  and UAS:eGFP/mCherry-HRasG12V 
expression vectors. B)  Mosaic oncogene expression is achieved by transient co-injection of 
the UAS effector DNA construct and transposase mRNA into one-cell stage eggs from the 
krtt1c19e:KalTA4-ERT2  stable transgenic line. C) Profile of zebrafish larval skin where, 
following transient injection, only cells in the basal skin layer that successfully integrate the 
UAS effector construct have the potential to express the oncogene. C’) For conditional 
oncogene expression KalTA4 has been fused to ERT2, which binds specifically 4-OHT. In the 
absence of 4-OHT the KalTA4-ERT2 is bound in the cytoplasm by heat-shock proteins. Upon 
4-OHT binding the heat-shock proteins-ERT2 complex dissociates, allowing the nuclear 
translocation of KalTA4-ERT2 and subsequent activation of the UAS controlled oncogene. 
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oncogene expression to isolated cells/group of cells within a normal epithelium 
would more realistically mimic the microenvironment of a pre-neoplastic lesion. 
The transformation of single cells in a mosaic manner can be achieved by the 
combinatory use of the stable transgenic line of one component together with 
the microinjection of a DNA construct carrying the other component. We used 
Tol2-transposase-mediated transgenesis [202] to generate a stable zebrafish 
line carrying krtt1c19e:KalTA4-ERT2 (Supplementary Figure 1) into which we 
transiently co-inject the UAS:mCherry/eGFP-HRasG12V construct 
(Supplementary Figure 3) and Tol2 transposase mRNA at the  one-cell stage 
(Figure 3.2.1A,B). 
The injected construct is randomly inserted into the genome of the developing 
embryo in a mosaic manner but only the cells within the basal skin layer have 
the potential to express the oncogene upon the introduction and continuous 
administration of 4-OHT (Figure 3.1 C-C’).  
Injected embryos are raised to larval stage and oncogene expression is 
induced at 2dpf (Figure 3.2.2 A). The KalTA4-ERT2/UAS system has been 
previously shown to induce detectable eGFP expression within 3 hours of 
treatment [237,238]. Our HRas model follows comparable activation kinetics 
with the first fluorescent cells detectable 4 hours after addition of 4-OHT using 
both a UAS:eGFP-HRasG12V or a UAS:eGFP-CAAX (membrane targeted 
eGFP) control plasmid. Within an hour, eGFP expression was detectable in 
isolated cells throughout the skin epithelia (Figure 3.2.2 B-B’’). The transient 
nature of the UAS component in the system and the increased length of the 
fusion protein may be the cause for the small delay in eGFP detection and 
observably reduced fluorescent intensity of eGFP-HRasG12V cells compared to 
eGFP-CAAX cells. 
It is important to verify correct subcellular localization of these proteins to 
assure proper interaction with their binding partners and consequent high 
fidelity signal transduction [239]. Both conditions display membrane bound 
eGFP. In each condition, the fluorescent protein seems to distinctly disperse 
within the membrane, despite having the same lipid anchor domain. In contrast 
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Figure 3.2.2 Transient injection of an oncogene expression plasmid allows mosaic 
generation of PNCs. A) Timeline of the experimental design B) Before induction no eGFP is 
detected other than cmcl2:eGFP transgenic selection marker in the heart. UAS driven 
expression of eGFP-CAAX control plasmid (B’) or eGFP-HRasG12V oncogene (B’’) is detected 
5 hours after induction in scattered cells in the skin. C-C’) mosaic transgene expression 
remains 24hpi. Scale bar = 200µm 
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to the even distribution of eGFP-CAAX throughout the plasma membrane, 
HRasG12V proteins, in agreement to previous data [240,241], preferentially 
aggregated in clusters potentially near specific membrane microdomains 
(Figure 3.2.2 B-B’’). The segregation of HRas could be a consequence of the  
repulsive force generated by the catalytic domain, lacking in our control 
plasmid [242]. 
As oncogene expression continues and eGFP fluorescence grows stronger 
the mosaic nature of this model remains (Figure 3.2.2 C, C’), revealing it to be 
a consequence of the transient injection rather than an irregular 4-OHT 
induction. To better understand the behaviour of these PNCs and their 
interaction with the microenvironment, I proceeded to characterise the model 
in more detail. 
 
3.3 Characterization of the PNCs Morphology and Behaviour 
 
The basal skin layer of the zebrafish larva is composed of polygonal shaped 
keratinocytes. These keratinocytes display the first signs of polarity at 3dpf 
when cytokeratin filaments localize the basal side of the cell [243]. 
Desmosomes maintain epithelial integrity and hemidesmosomes anchor them 
to the basement membrane laying underneath [175,243]. 
Cell motility and organization of the actin cytoskeleton are some of the 
mechanisms under Ras signalling regulation. Important mechanisms for the 
establishment and maintenance of oncogenic Ras transformation include 
cortical actin rearrangement, downregulation of cell adhesion molecules and 
degradation of extracellular matrix which can drastically change cell polarity 
and morphology [66]. Analysis of the cell morphology and behaviour can then 
be indicative of the mechanisms involved in the oncogenic Ras transformation 
of PNCs in our model for tumour initiation. 
Observation of the polygonal shaped control eGFP-CAAX expressing cells at 
different time-points allowed the confirmation that membrane targeting of a 





Figure 3.3.1 Characterization of cell morphology over time. A) Maximum intensity 
projection of eGFP-CAAX expressing cells (top panel) and PNCs (lower panel) at 12, 24 and 
48 hpi. Control cells exhibit consistent epithelial morphology at all time-points. In contrast, 
PNCs develop a distinct morphology since early time-points. Arrowheads point to membrane 
domains of high eGFP intensity as an indication of eGFP-HRasG12V protein accumulation. B) 
Frequency of the morphology of different types of PNC aggregates at different time-points. 
Examples of the three different types of PNC aggregates can be seen in (A). Data acquired 
from 3 independent experiments; n³ 10 per time-point. Scale bar = 50 µm.   
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These cells exhibited consistent epithelial morphology at all time-points. 
Conversely, PNCs, displayed a very dynamic architecture (Figure 3.3.1 A, B). 
At 12hpi, PNCs had developed a slightly rounder morphology than the control 
cells. The eGFP-HRasG12V protein aggregates accumulated preferentially in 
membrane domains in contact with other PNCs  (Figure 3.3.1 A, arrowheads), 
suggesting these cells were capable of recognising each other and 
establishing a cross-talk. 
At 24hpi, cell morphology diversifies with most PNCs acquiring a more 
stretched and elongated shape. At this stage, some PNC aggregates were no 
longer part of an organised monolayer epithelial sheet as seen in earlier time-
points, and seem to have lost their polarity and aggregated into three-
dimensional disorganised masses. At 48hpi, there was a decrease in the 
proportion of stretched cells and aggregates of round cells were found more 
frequently (Figure 3.3.1 A, B).  
Live time-lapse imaging revealed cell elongation and epithelial disorganization 
to be a result of what appeared to be partial epithelial-to-mesenchymal 
transitions (EMTs) characterized by the formation of cellular protrusions 
(Figure 3.3.2 A, supplementary video 1), increasingly dynamic interaction 
between PNCs with rapid association and dissociation of cells and, ultimately, 
cell movement (Figure 3.3.2 B, supplementary video 2). Isolated PNCs often 
exhibited more static behaviour suggesting the importance of the crosstalk 
between cells to potentiate oncogene signalling activity and, consequently, 
EMT induction (Figure 3.3.2 A). Occasionally, PNC extrusion is also observed 
(Supplementary Figure 6), although not often enough for the mechanisms 
behind it to be properly understood without the appropriate studies. To better 
understand the mechanisms that mediate this highly dynamic PNC behaviour 
I performed qRT-PCR analysis of whole larvae for the EMT associated gene 
mmp9 and found it is upregulated in PNC-bearing larvae (Figure 3.3.2 C).  
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Figure 3.3.2 PNCs exhibit dynamic behaviour which resembles partial EMT. A) Still 
images of a 1 hour long time lapse movie from 24hpi showing the dynamic behaviour of PNCs 
with active rearrangement of PNCs, formation of protrusions (arrowheads) occasionally with 
interaction with other distant PNCs. Isolated PNCs (asterisks) retain a more static behaviour. 
B) Still images of a 24 hour long time lapse movie from 12hpi showing active rearrangement 
of PNCs and the movement of a PNC across the flank of the larva (cell 2) C) qRT-PCR was 
performed on pooled whole larvae at 24hpi for the EMT related gene mmp9. 
Mean Ct of three technical replicates were normalized to housekeeping genes, rps11 and 
gapdh (DCt), and then normalized to a CAAX control (DDCt). Graph reads relative expression  
calculated as 2-(MeanDDCt±SEMDDCt). n= 6 per group. Multiple Student t test with Holm-Sidak post-
test were performed on DCt values. **p=0.0011. Scale bar = 50 µm.  
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3.4 Characterization of PNC Proliferative Capacity 
 
Uncontrolled PNC proliferative capacity which overpowers normal epithelial 
expansion is a key determinant for PNCs to establish dominance over 
neighbouring cells and expand into tumours. Being a key regulator of cell cycle 
and cell proliferation, the continuous activation of the HRas signalling pathway 
through the expression of the HRasG12V oncogene, has the potential to 
promote PNC over-proliferation. 
Considering the stochasticity of the number and distribution of PNCs, a 
characteristic of the transient injection used for their generation, coupled with 
their high motile nature, the quantification of number of cells or size/area of 
PNC clones, used by others [154,244], would not be an accurate measurement 
of proliferation. Instead, cell proliferative capacity was quantified as the 
proportion of PNCs which had incorporated a detectable nucleoside analogue 
of thymidine, 5-ethynyl-2'-deoxyuridine (EdU), into their DNA over a 2.5-hour 
period. EdU incorporation was thus used as an indication that a cell had gone 
through DNA replication. 
Initially, at 12hpi, 10.7±0.7 % of the PNCs exhibited proliferative capacity, 
however, this was not significantly higher than the control CAAX cells with 
6.88±1.12 % proliferating cells (Figure 3.4.1 B). This is likely to be a result of 
a high basal level of skin proliferation in 2-3 dpf embryos due to their rapid 
growth and development rather than a consequence of low HRAS signalling 
[178,245]. This hypothesis was supported by the analysis of later time-points, 
when proliferation of PNCs was significantly and progressively higher, 
reaching 43.2±2.5 % at 36hpi (Figure 3.4.1 A, B). In contrast, CAAX control 
cells exhibited a decreasing proliferative capacity, lower than 1% at 36hpi, as 
skin cell proliferation and larva growth slowed. 
Interestingly, cells immediately surrounding the PNC clones had also become 
more proliferative (Figure 3.4.1 C). With no additional tissue specific marker, it 
was not possible to determine which cell types were proliferating. 
Nevertheless, the observation of EdU positive nuclei in proximity with all 
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Figure 3.4.1 PNCs acquire increasing proliferative capacity and induce proliferation of 
neighbouring cells. A) Maximum intensity projection of confocal images of CAAX control 
cells (top panel) and PNCs (lower panel) following EdU detection and eGFP/HRas 
immunostaining of 36hpi larvae. Asterisks indicate eGFP/EdU double positive cells. B) 
Quantification of double positive cells at different time-points was performed by optical 
sectioning. C) Proliferation in neighbouring cells was measured as the number of EdU positive 
nuclei within 10 µm distance from the boundaries of eGFP positive cells normalized to the total 
number of eGFP expressing cells. Data acquired from 3 independent experiments; n³ 7 per 
time-point, per group. Mean±SEM. 2 Way ANOVA with Sidak’s post-test. * p= 0.0209; *** 
p=0.0004; **** p<0.0001. Scale bar = 50 µm. 
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3.5 Detection of Pre-Neoplastic Cell Death 
 
Pre-cancerous lesions are often associated with a high incidence of apoptosis. 
This was shown to be consequence genomic instability caused by oncogene 
activation [246]. Activated oncogenes induce the collapse of replication forks 
causing double strand DNA breaks (DSBs) which will consequently induce a 
DNA damage response and p53-dependent cell cycle arrest, apoptosis or 
senescence [247,248]. Continuous observation of PNCs shows that, from 
24hpi onwards, PNC clones tend to decrease in area, suggesting cell death is 
a characteristic of our model. Live time lapse imaging has allowed me to 
confirm this assumption by the observation of cells bursting into several 
vesicles and disappearing, in an undetermined type of cell death (cell on top 
left corner of Figure 3.3.2 A). 
Given that only the final stage of apoptosis is morphological distinct and can 
be quickly cleared by phagocytes, an appropriate staining protocol was 
performed to detect the proportion of PNCs going through apoptosis at any 
given time-point. The Terminal deoxynucleotidyl Transferase-dUTP Nick End 
Labelling (TUNEL) assay is based on the incorporation of modified dUTPs by 
the enzyme terminal deoxynucleotidyl transferase (TdT) at the 3’-OH ends of 
DNA strand breaks. Since DNA damage is considered the main cause for 
oncogene-induced apoptosis at a pre-neoplastic stage, TUNEL staining was 
chosen to assay apoptosis. 
Successful staining revealed PNCs sustained DNA damage which is indicative 
of apoptosis (Figure 3.5.1 A).  Contrary to larvae with CAAX control cells, which 
showed minimal TUNEL staining, larvae with skin pre-neoplastic lesions 
exhibited a progressively higher proportion of eGFP/TUNEL double positive 
cells (Figure 3.5.1 B). There were also high levels of TUNEL staining in what 
appeared to be the superficial skin cell layer above some of the larger PNC 
clones, which suggests that the presence of PNCs on the basal skin layer 





Figure 3.5.1 TUNEL staining showed increased cell death in PNCs and in the superficial 
cells immediately above them. A) Maximum intensity projection of confocal images of CAAX 
control cells (top panel) and PNCs (lower panel) following TUNEL staining and eGFP/HRas 
immunostaining of 24hpi larvae. A’) Orthogonal views of 3 different XZ planes of the composite 
image in the PNC condition in (A) showing positive staining above the basal keratinocyte layer. 
Arrowheads in (A) and (A’) indicate eGFP/EdU double positive cells. B) Quantification of 
double positive cells at different time-points was performed by optical sectioning. Data 
acquired from 2 independent experiments; n³ 11 per time-point, per group. Mean±SEM. 2 
Way ANOVA with Sidak’s post-test. *** p=0.0002: **** p<0.0001. Scale bar = 50 µm. 
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3.6 PNCs Induce an Inflammatory Response 
 
Several studies have shown that oncogenic Ras signalling induces the 
expression of several inflammatory mediators and initiates the establishment 
of an inflammatory milieu that promotes the survival of transformed cells. The 
ability of PNCs to elicit an inflammatory response could then be determinant 
for the progression of these cells into tumour masses.  Neutrophils, 
specifically, are very sensitive to the smallest inflammatory cues and often the 
first cell type to be recruited to an inflammation site [249,250], therefore they 
may be interesting players in oncogene induced inflammation. 
We, and others, have previously established that the presence of PNCs from 
a variety of cell lineages in the skin of larval zebrafish leads to an inflammatory 
response with recruitment of neutrophils and macrophages 
[149,150,154,160,206]. To explore whether our inducible basal skin layer 
model initiates a comparable inflammatory response, we crossed the 
krtt1c19e:KalTA4-ERT2 zebrafish driver line with the neutrophil specific 
lyz:DsRed transgenic zebrafish line [199]. Typically, at 2-3 dpf, 
unchallenged/inactivated neutrophils remain in the caudal hematopoietic 
tissue (CHT), head mesenchyme and over the yolk [198]. The presence of 
PNCs in the keratinocyte lineage of the basal skin layer promotes the 
recruitment of neutrophils to the skin near these lesions. The inflammatory 
insult occurs almost immediately after the appearance of the PNCs as 
neutrophils were observed being recruited to eGFP-HRasG12V expressing cells 
in the skin as early as 5hpi (Figure 3.6.1 A-B). 
Live, time-lapse imaging of these larvae for 24 hours allowed me to monitor 
the progression of the inflammation over time. An increasing number of 
recruited neutrophils could be seen near the PNCs, opposed to the CAAX 
control cells which did not generate any inflammatory response from 
neutrophils (Figure 3.6.1 C-E, supplementary video 3). After reaching a peak 
recruitment capacity, at 24-25hpi, the number of recruited neutrophils remains 
elevated, suggesting a chronic inflammation setting [154]. To determine which 
pathways might be involved in neutrophil recruitment to the PNCs, I performed 
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qRT-PCR for inflammatory cytokines and chemokines which are known 
neutrophil chemo-attractants. I found the presence of PNCs in the skin leads 
to the upregulation of the pro-inflammatory cytokine Il-1 and the chemokines 
Cxcl8 and Cxcl18b (Figure 3.6.1 F). 
 
 
Figure 3.6.1 PNCs induce an inflammatory response from very early stages which 
evolve into a chronic inflammatory microenvironment. A) Still image from a time lapse 
movie showing the recruitment of neutrophils to the skin at 5hpi and their movement tracks in 
the following 45 minutes towards the PNCs. B) Number of neutrophils recruited to the skin 
within a 6-somite-wide area at 5hpi. Data acquired from 2 independent experiments; n³ 30 per 
group. Mean±SEM. Mann-Whitney test. C) Still image from a time lapse movie showing  
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Figure 3.6.1 (continued) neutrophils remain in the CHT in the CAAX control condition D) Still 
image of equivalent time-point from a larva with PNCs showing active neutrophil recruitment. 
E) Number of neutrophils recruited to the skin through the course of a 24-hour time lapse 
movie. Data acquired from 2 independent experiments; n³ 8 per group. Mean±SEM. 2 Way 
ANOVA with Sidak’s post-test. F) qRT-PCR was performed on pooled whole larvae at 24hpi 
for the pro-inflammatory genes il-1, cxcl8 and cxcl18b and analysed as in Fig 3.3.2. n= 6 per 




For a long time, cancer research was restricted to the study of late stage 
tumour development. The inability to detect pre-neoplastic lesions and follow 
their interactions with the surrounding tissues in vivo have made it difficult to 
establish the chronology and signalling events of tumour initiation. Here I 
present an in vivo model taking advantage of the genetic tractability and optical 
transparency of the zebrafish to overcome those issues. This new system for 
temporal control of the mosaic expression of the HRasG12V oncogene in the 
translucent zebrafish larval skin epithelia allows a non-invasive approach for 
the early detection of PNCs in vivo and the study of the mechanisms that 
initiate tumour formation. Considering the considerable morphological and 
functional similarities between the zebrafish larval skin and mammalian 
epithelial tissues such as lung, prostate, mammary gland, colon and kidney 
[176,178,182,183], the relevance of this study is not limited to the keratinocyte 
derived cutaneous squamous cell carcinogenesis and parallels can be drawn 
with tumour initiation in epithelial tissues coating mammalian internal organs 
which are inaccessible to high resolution in vivo studies. 
Transformation of keratinocytes in the superficial skin layer of the zebrafish 
larva had been previously achieved by us and others [150,206]. The basal skin 
layer, however, containing the epidermal stem cell compartment which 
contributes to all layers of the adult epidermis [177], may be of greater 
biological relevance for cancer studies. 
This model allowed the generation of detectable isolated pre-neoplastic 
lesions in a keratinocyte lineage which exhibited progressive signs of 
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oncogene transformation, namely their increasing proliferative capacity, 
epithelial cell plasticity, DNA damage, increasing cell death and release of pro-
inflammatory signals.  
Previous studies have demonstrated transformed cells fail to proliferate within 
a normal epithelium and cell competition mechanisms promote their 
elimination [232–235]. The observation of cell extrusion and apoptotic cell 
death in our model suggests similar mechanisms are in place but the increased 
proliferative capacity of the PNCs makes me believe they are capable of 
initiating processes to counteract this suppressive environment. In previous in 
vitro studies, the extension of basal protrusions  and consequent translocation 
to  the underlying collagen  or apical extrusion have been shown to allow clonal 
expansion [232,235]. The activity of MMPs seem to be important for this 
translocation [235]. Disruption of cell-cell junctions via gene downregulation or 
displacement of E-cadherin or b-catenin proteins in the neighbouring cells 
could also counteract suppression of proliferation [235]. The observation of 
similar behaviours, such as apical extrusion and basal protrusions coupled 
with upregulation of mmp9, suggests active re-structure of the extracellular 
matrix may enable dynamic PNC interactions and movement facilitating 
evasion of the suppressive epithelium. Despite the evident dynamic 
morphology of PNCs, the mechanisms behind the cellular plasticity and 
mobility seen in this model are yet to be fully characterized. Whether disruption 
of epithelial integrity of neighbouring cells occurs also remains to be confirmed. 
A more detailed analysis of the cell structure would greatly complement this 
study. Assessment of subcellular localization of the keratin filaments and cell 
junctions is required to determine PNC loss of polarity. The study of other EMT 
associated genes expression, such as vimentin, would help understand the 
mechanisms behind the increasing PNC plasticity. 
A recent study on oncogene transformed keratinocytes in the zebrafish 
superficial skin layer showed that Cxcr2 dependent neutrophil recruitment is 
required for  pre-neoplastic cell dynamic behaviour and EMT-related genes 
upregulation [150]. Our results, showing coincidence of a peak neutrophil 
recruitment time-point and the highly dynamic behaviour of the PNCs around 
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24hpi agree with this finding. However, it does not explain why, at 48hpi, when 
neutrophils are still actively recruited, this EMT like behaviour is less frequently 
detected. 
It remains unclear whether the decrease in elongated, highly dynamic pre-
neoplastic lesions overtime is a result of alteration of these cells to a rounder 
stem-like morphology, or the positive selection of originally less differentiated 
transformed cells and elimination of elongated cells. Several studies have 
shown that the clonogenic potential of an oncogene-transformed cell is 
determinant in its ability to respond to tumorigenic stimuli and that transformed 
stem cells are more likely to develop into tumours in vivo [228,251,252]. On 
the other hand, it is possible that the constitutive active Ras signalling coupled 
with extrinsic factors, such as, the  inflammatory microenvironment are 
promoting the phenotypic changes of these PNCs. Many inflammatory 
mediators can regulate the transcriptional signature of cancer cells and 
facilitate tumorigenic features such as self-renewal and migration [253]. A 
more comprehensive study of the heterogeneity of these cells is required.    
The increasing amount of DNA damage and cell death detected with TUNEL 
staining indicates PNCs suffer genomic instability which can trigger DNA 
damage responses (DDR) that induce apoptosis. The overexpression of 
HRasG12V could be directly responsible for that genomic instability through the 
induction of DNA replication stress [254–256]. The activation of different 
oncogenes has been associated with loss of heterozygosity and genomic 
instability [12,248]. Oncogenic Ras was found to cause chromosomal 
anomalies within one cell cycle in murine fibroblasts [257]. This oncogene-
induced replicative stress seems to preferentially affect common fragile sites 
which are also  often found compromised in naturally occurring pre-neoplastic 
lesions [258,259]. Oxidative stress induced in a chronic inflammatory 
environment can also cause genomic instability in a pre-cancerous stage [81]. 
The recruited neutrophils, which are present from very early stages in this 
model, could release reactive oxygen species into the environment causing 
additional DNA damage [260]. 
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Given the potential for genomic instability, one cannot disregard the possibility 
that PNCs may acquire additional mutations. Mutations in genes that regulate 
DDR and cell proliferation would confer a survival advantage to PNCs making 
them more capable of surviving and evolving into neoplastic lesions [12,15]. 
This is consistent with our observations of surviving PNCs at later time-points 
with higher proliferative capacity. 
Dying cells could also be triggering a form of compensatory proliferation in 
neighbouring living PNCs. Research on tumour re-incidence after cytotoxic 
therapy have uncovered some of the mechanisms involved. Namely, apoptotic 
tumour cells have been shown to stimulate proliferation of living tumour cells 
via caspase3-iPLA2 dependent induction of PGE2 secretion [261,262], 
activation of the caspase3/7-PKCδ-AKT/p38 MAPK pathway [263] and 
activation of the caspase3/PKCδ/p38/MNK1 pathway [264]. The release of 
HMGB1 following necrosis was also found to induce proliferation through 
RAGE ligand binding dependent activation of ERK and p38 signalling 
pathways [265]. However, these mechanisms have not yet been shown in a 
pre-cancerous stage. 
Considering the low specificity of TUNEL staining, in the sense that free 3’-OH 
termini can arise from mechanisms other than apoptosis, these results must 
be interpreted with caution [266,267].  TUNEL staining has been shown to be 
equally sensitive to other types of cell death, such as necrosis and autolysis 
[268]. It can also falsely label cells undergoing DNA repair or undergoing active 
gene transcription [269]. Some studies have also addressed how the method 
and duration of tissue fixation [270] as well as post-fixation processing of the 
tissue  [271] can damage DNA. Nevertheless, the little staining detected in the 
CAAX control samples which went through the same fixation and proteinase 
K treatment method assures us this is not likely to have happened here. Given 
the susceptibility for TUNEL staining to give false positive results, it should only 
be considered as a method for DNA damage. Even though time lapse imaging 
gave irrefutable evidence of PNC death, the proportion of cells in which it 
occurs may have been overestimated. A secondary apoptosis-specific 
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staining, such as cleaved-caspase 3 immunofluorescent staining, should be 
performed to confirm that cell death occurs through apoptosis. 
The high levels of TUNEL positive staining above wider areas of PNC 
aggregates, presumably in the superficial cell layer, suggest these cells suffer 
a great incidence of DNA damage and potential cell death. Scanning electron 
microscopy images of these pre-neoplastic lesions taken by our collaborators 
in Paul Martin’s Laboratory, University of Bristol, show the loss of superficial 
cells immediately above basal layer PNCs, corroborating our TUNEL staining 
[van den Berg et al, unpublished]. The lesion overgrowth coupled with the 
highly dynamic PNC movement and rearrangement of extracellular matrix by 
metalloproteinases in the basal skin layer may be responsible for local loss of 
integrity of the superficial skin layer. 
Another interesting consequence of the presence of PNCs is the high 
proliferation in neighbouring cells. This observation exposes the possibility of 
a non-cell-autonomous mechanism for overgrowth which has been extensively 
explored in Drosophila studies [272,273]. For instance, a Drosophila model for 
tumour-stroma interaction has highlighted the importance of the cross-talk 
between epithelial and mesenchymal cells via Wg/WNT and Dpp/TGF-b 
signals from the tumour epithelial cells to support expansion of both 
compartments [274]. Recently, it was also shown that oncogene induced 
senescence caused by HRasG12V activation and mitochondrial dysfunction in 
Drosophila imaginal epithelium promotes hyperplasia of wild type 
neighbouring cells through JNK-Yki dependent release of Upd⁄IL-6 [275]. Work 
done by a fellow colleague, Lisa Kelly, has revealed that PNCs in the 
superficial skin layer have impaired respiratory capacity due to mitochondrial 
dysfunction. However, whether that effect is replicated in the PNCs from the 
basal layer and whether it promotes oncogene-induced senescence it is not 
yet known.  
Finally, I was able to demonstrate HRasG12V overexpression in keratinocytes 
can induce an inflammatory response comparable to previous models 
[149,150,154,160,206]. The upregulation of the pleiotropic pro-inflammatory 
cytokine Il-1 and the continuous recruitment of neutrophils indicate this 
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oncogene can initiate a chronic inflammatory environment in pre-neoplastic 
lesions. The very early detection of PNCs by neutrophils suggests the PNCs 
themselves, directly or indirectly, release signals for this effect. Several studies 
have shown oncogene-induced release of pro-inflammatory cytokines and 
chemokines into the microenvironment [67,69,73,77,154]. Amongst them, 
CXCL8 is of great interest for its role in neutrophil chemotaxis. Acute 
inflammation studies have shown this function is conserved in zebrafish larvae 
[249,276–280]. Cxcl18b was also associated to neutrophil recruitment in a 
zebrafish inflammation model [281].  The upregulation of these chemokines 
seen in larvae carrying a PNC burden suggests Cxcl8 and Cxcl18b are 
responsible for the neutrophil recruitment to PNCs. This is consistent with 
recent reports which demonstrated the involvement of these chemokines 
receptors in neutrophil recruitment in early tumorigenesis. Treatment with 
Cxcr2 and Cxcr1 inhibitors was found to block neutrophil recruitment to 
transformed epithelial cells and astrocytes, respectively [149,150].  
In summary, we were able to establish a tissue specific inducible model to 
generate pre-neoplastic lesions and study the mechanisms that initiate tumour 
formation. The observation of behaviours similar to naturally occurring pre-
cancerous lesions, such as increasing proliferative capacity, epithelial cell 
plasticity, DNA damage and increasing cell death, confirms this model mimics 
the mechanisms involved in epithelial tumour initiation. The early onset of an 
inflammatory response points to inflammation as a potential mediator of the 
mechanisms discussed here and the consequent progression of these cells 
into tumour masses. The following chapters will explore the role of an 
inflammatory signalling pathway in the progression of pre-neoplastic lesions. 
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4 NF-kB Pathway Activation in PNCs Modulates Neutrophil 




Inflammation has long been considered an enabling characteristic of the 
cancer microenvironment [5,282]. As a result of its role as a pivotal regulator 
of inflammation, NF-kB activity has been implicated in a variety of cancers [85]. 
Constitutive activation of this signalling pathway promotes the release of 
growth and survival factors, extracellular matrix-modifying enzymes and other 
bioactive molecules by tumour and stromal cells into the tumour 
microenvironment contributing to the acquisition of cancer hallmark 
capabilities [85].  
However, due to the wide scope of mechanisms regulated by NF-kB 
transcriptional activity, its role in tumorigenesis is quite complex, exhibiting 
both tumour promoting and tumour suppressive effects. The investigation of 
the role NF-kB in development of skin cancer has particularly met contradictory 
results. It is well documented that squamous cell carcinomas constitutively 
activate NF-kB, which contributes to their survival, growth and pro-
inflammatory microenvironment [283–285]. However, downregulation of NF-
kB activity in normal epithelia allows for spontaneous generation of squamous 
cell carcinoma through TNF mediated inflammation [128,141,143,144]. These 
results indicate NF-kB could play conflicting roles in tumour development 
depending on the stage of progression. In line with its importance in the 
regulation of differentiation and immune homeostasis of normal skin, NF-kB is 
thought to suppress tumour initiation [286,287]. In the event of an oncogenic 
insult, NF-kB signalling switches to favour the activation of tumour promoting 
mechanisms [129,288]. With regards to oncogenic Ras driven tumour 
initiation, NF-kB signalling has been suggested to play a pro-tumorigenic role 
from a very early stage. Several in vitro studies have suggested NF-kB to be 
a downstream target of oncogenic Ras signalling. Activation of the 
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transcriptional function of the NF-kB RelA/p65 subunit by oncogenic Ras 
signalling was shown to be required for cellular transformation [69,117–124]. 
In a study using the DMBA/TPA two stage chemical skin carcinogenesis 
model, which is often associated with oncogenic Ras mutations, researchers 
were able to mechanistically separate the initiation and promotion stages of 
tumour development and evaluate the role of NF-kB in each stage [129]. In 
this study, during tumour initiation, NF-kB prevents cell death induced by 
DMBA mediated DNA damage. Following DMBA treatment, NF-kB is 
important for TPA induced release of cytokines and chemokines that promote 
skin inflammation and epidermal hyperplasia [129]. 
Further analysis into the mechanisms activating NF-kB signalling in 
transformed keratinocytes have shown sustained activation of NF-kB requires 
the establishment of an autocrine loop through IL-1α-IL-1R-MyD88 signalling 
[130]. Production of IL-1a is downstream of EGFR, and both MAPK and PKCa 
pathways have been implicated in this autocrine loop [130,289]. The 
importance of NF-kB signalling in tumour development is not limited to its 
direct role in the expression of pro-inflammatory, survival and mitogenic factors 
and has been implicated in the amplification of other positive autocrine loops 
of Ras signalling. For instance, NF-kB dependent expression of CXCR2 
ligands potentiates activation of ERK and AKT pathways [290].  
Furthermore, NF-kB has been suggested to promote early tumour 
development by suppressing immune cell surveillance. NF-kB activation in 
tumour cells allows them to evade macrophage cytotoxicity by upregulating 
anti-apoptotic genes and releasing soluble factors, such as GDF-15, which 
block macrophage synthesis of TNF and NO [288,291]. Conversely, the role 
for NF-kB activation in the modulation of neutrophil cytotoxicity in tumour 
initiation is less well known. 
In this Chapter, I demonstrate that the activation of NF-kB signalling is a very 
early event of tumour development. I then analyse how the suppression of this 
signalling pathway affects PNC proliferation and neutrophil behaviour. 
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4.2 Detection of NF-kB Activity in PNCs 
 
Following the detection of a persistent inflammatory microenvironment from 
very early stages of PNC emergence, I pursued a characterization of the 
signalling pathways involved in its regulation. The upregulation of known NF-
kB target genes (mmp9, il-1, cxcl8, cxcl18b) (see Chapter 3) observed in this 
model directed me to NF-kB as a likely regulator of PNC induced inflammation. 
I characterized NF-kB activity in the PNC environment by crossing the 
superficial skin layer specific krt4:KalTA4-ERT2 zebrafish driver line [206] with 
a previously published NF-kB activity reporter zebrafish line [207]. In this 
Tg(NFkB:eGFP) reporter line, eGFP is under the transcriptional control of 6 
concatenated NF-kB recognition sequences which drive eGFP expression 
upon the activation and translocation of NF-kB transcription factors to the 
nucleus, allowing temporal and spatial detection of NF-kB activity [207].  
In vivo, time-lapse imaging of PNC bearing larvae revealed increasing eGFP 
expression over time, indicative of continuously high levels of NF-kB activity 
(Figure 4.2.1 A-B, Supplementary video 4).  EGFP intensity in the PNCs 
revealed an increasing slope and reached a 10.6±1.6 fold change by 24hpi, 
with 59.5±3.0% double positive cells (Figure 4.2.1B-D). CAAX control cells 
showed little variation of eGFP intensity over time, reaching 2.1±0.2 fold 
increase within 14 hours (Figure 4.2.1 A-B). These results are consistent with 
the current knowledge of the critical role of a finely regulated NF-kB activity in 
the maintenance of keratinocyte homeostasis [286,287,292] and point to this 
signalling pathway as a potential key regulator of the inflammatory response 




Figure 4.2.1 PNCs show high levels of NF-kB activity. A) Still images from 14 hour time-
lapse movies (10-24 hpi) showing activation of the NF-kB:eGFP reporter in PNCs. B) 
Quantification of mean eGFP intensity in mCherry expressing cells from 10-24 hpi. C) Fold 
change of eGFP intensity in mCherry expressing cells between 10hpi and 24hpi. To account 
for variation due to differences in transgene copy number mean intensity values within each 
larva were normalized to eGFP expression level in the lateral line at 10hpi. D) Quantification 
of eGFP/mCherry double positive cells at 10hpi and 24hpi was performed by optical 
sectioning. Data acquired from 3 independent experiments; n=12 per group. Mean±SEM. (B) 
Correlation with Squared Pearson’s Coefficient. (D) 2 Way ANOVA with Sidak’s post-test. 
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Figure 4.2.1 (continued) (C) Mann-Whitney test. * p= 0.0242; **p<0.01; *** p=0.0005; **** 
p<0.0001. Scale bar = 50 µm. 
 
4.3 Characterization of myd88 Gene Upregulation in the PNC Niche 
 
As an extremely important intermediate of NF-kB dependent signalling, the 
MyD88 adaptor protein has also been associated with the mechanisms 
involved in the pro-tumorigenic inflammatory response. The importance of this 
protein in tumour formation is not limited to the maintenance of the 
autocrine/paracrine production of NF-kB mediated factors and has also been 
shown to exert a cell intrinsic role in the amplification of the Ras canonical 
signalling pathway [130,132,293–295]. Upregulation of MYD88 gene 
expression has been detected in a variety of human primary cancer tissues 
and is often associated with poor prognosis [296–298]. Following the initial 
observation that emerging preneoplastic cells induce an inflammatory 
response, I wanted to determine if myd88 expression changed in the early 
stages of tumour initiation.  
To study myd88 gene expression I crossed the basal skin layer specific 
krtt1c19e:KalTA4-ERT2 zebrafish driver line to a previously published myd88 
gene expression reporter zebrafish line [208]. In this Tg(myd88:DsRed2) 
reporter line, DsRed2 is under the control of the »3.7 kb long genomic 
sequence immediately upstream of the myd88 initiation codon.  
Observation of PNCs over time showed myd88 gene upregulation from 36hpi 
onwards and by 48hpi nearly 30% of PNCs had detectable DsRed expression 
(Figure 4.3.1 A-C). myd88 upregulation was also detected in neighbouring 




Figure 4.3.1 myd88 expression is induced in PNCs and neighbouring cells. A) Maximum 
intensity projection of live confocal images of CAAX control cells (top panel) and eGFP-
HRasG12V PNCs (lower panel) showing expression of DsRed as a reporter of myd88 gene 
upregulation in a subset of PNCs and in the surrounding cells at 48hpi. B) Quantification of 
eGFP/DsRed double positive cells at different time-points performed by optical sectioning. C-
D) Quantification of DsRed mean intensity in aggregates of eGFP expressing cells (C) and 
neighbouring cells within 25 µm distance from of eGFP positive cells (D). Data acquired from 
3 independent experiments; n³10 per group, per time-point. Mean±SEM. 2 Way ANOVA with 
Sidak’s post-test. **** p<0.0001. Scale bar = 50 µm. 
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4.4 Inhibition   of   MAPK   Signalling   Does   Not   Affect   NF-kB   Activity   
in   PNCs 
 
NF-kB activation can be induced by over 150 stimuli [84]. Following oncogenic 
Ras transformation several downstream effector targets have been shown to 
activate NF-kB signalling and consequently promote oncogene induced 
inflammation [123,124,126,299]. Murine studies identified the MAPK pathway 
and, more specifically, Erk1/2 phosphorylation to be upstream of NF-kB 
dependent upregulation of Il-1, Mmp9 and Cox2 expression [118,289,300]. 
The upregulation of pro-inflammatory genes detected in this model suggests 




Figure 4.4.1 NF-kB activity in PNCs is not affected by MEK inhibition. A) Schematic figure 
of experimental procedure showing time points and duration of treatment. B) Schematic figure 
of MAPK signalling pathway showing at which level Trametinib exerts its inhibitory effect. C) 
Quantification of eGFP mean intensity in aggregates of mCherry expressing cells at 18hpi 
following 0.5% (v/v) DMSO or 5µM Trametinib treatment. To account for variation due to 
differences in transgene copy number mean intensity values within each larva were 
normalized to eGFP expression level in the lateral line at 9hpi. Data acquired from 2 
independent experiments; n=18 per group. Mean±SEM. Mann-Whitney test. ns p>0.9999 
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To test this hypothesis PNC bearing, NF-kB reporter larvae were treated with 
the MEK inhibitor Trametinib, which has been reported to successfully 
abrogate Erk phosphorylation in zebrafish [301]. To allow for effective MEK 
inhibition larvae were treated for 8-9 hours from the detection of PNCs (Figure 
4.4.1 A-B). Image analysis of Trametinib treated and DMSO treated control 
larvae showed no difference in eGFP expression suggesting NF-kB activity 
was not Erk dependent (Figure 4.4.1C). 
 
4.5 The Intrinsic Role of NF-kB in the PNC Proliferation 
 
A major pro-tumorigenic role of NF-kB signalling is its effect on the regulation 
of proliferation. By promoting the release of regeneration enhancing cytokines 
and the expression of growth factors, NF-kB activation has the potential to 
promote the proliferation of tumour cells. 
A transgenic line previously established in the laboratory that allows for cell 
lineage specific suppression of NF-kB activity was used to assess the role of 
NF-kB activation in PNC proliferation. In this model, NF-kB suppression is 
achieved through the overexpression of a constitutively active dominant 
negative mutant form of the murine IkBa, IkBSR. This mutant IkBa is resistant 
to phosphorylation and consequent proteasome degradation, thus, retaining 
NF-kB in the cytoplasm and preventing its translocation to the nucleus 
[302,303]. Well described and used extensively in mammalian systems, IkBSR 
has also been shown to inhibit NF-kB signalling in zebrafish embryos 
[304,305]. To determine the effect of diminished NF-kB signalling in PNCs, I 
crossed Tg(UAS:IkBSR) with Tg(krtt1c19e:KalTA4-ERT2) enabling 
KalTA4/UAS mediated expression of IkBSR specifically in keratinocytes of the 
larval basal skin layer upon 4-OHT treatment (Figure 4.5.1, A). As explained 
in the previous chapter, EdU incorporation was used as an indication of PNC 
proliferative capacity. As expected, PNCs with induced suppression of NF-kB 
signalling displayed a significantly lower proliferative capacity at 24hpi. In 
comparison to the »31% proliferation rate of WT PNCs at this time-point, only 
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»22% of PNCs exhibited proliferative capacity in an IkBSR background (Figure 
4.5.1, B). This result suggests an intrinsic role for NF-kB signalling in 
promoting PNC proliferation. 
 
 
Figure 4.5.1 NF-kB activity promotes PNC proliferation. A) Schematics of how basal skin 
layer specific suppression of NF-kB activity is achieved in this model of tumour initiation. B) 
Percentage of proliferating PNCs in krtt1c19e:IkBSR transgenic larvae and their WT siblings 
at 24hpi. Quantification of double positive cells following EdU detection and eGFP/HRas 
immunostaining was performed by optical sectioning. Data acquired from 2 independent 
experiments; n³ 16 per group. Mean±SEM. Mann-Whitney test. *** p=0.0004.  
 
4.6 NF-kB Signalling in PNCs Affects Neutrophil Retention but Not 
Recruitment 
 
Several chemokines are amongst the proinflammatory factors downstream of 
MyD88-NF-kB signalling in oncogenic Ras transformed keratinocytes. It is well 
established that chemokines expressed by cancer cells, are major 
chemoattractants of neutrophil recruitment and infiltration within tumour 
microenvironment . As a potential upstream regulator of these chemokines 
expression, NF-kB signalling may be one of the mechanisms promoting 
neutrophil recruitment to PNCs. However, contrary to expectations, live time 
lapse imaging of PNCs in krtt1c19e:IkBSR transgenic larvae revealed only a 
slightly lower number of recruited lyz:DsRed positive neutrophils, when 
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compared to their WT siblings (Figure 4.6.1). While the results shown here 
display no statistical significance, conclusions should be drawn cautiously, 
considering the small size of the sample. As such, this experiment, should be 
repeated a few more times to generate more powerful statistics. 
 
 
Figure 4.6.1 Inhibition of NF-kB signalling in the PNCs has little effect on recruitment of 
neutrophils to PNCs. Number of lyz:DsRed positive neutrophils recruited to PNCs in 
krtt1c19e:IkBSR transgenic larvae and their WT siblings through the course of a 3-hour long 
time lapse movie at 24hpi. Data acquired from 3 independent experiments; n=4 per group. 
Mean±SEM. Mann-Whitney test. ns p=0.0571. 
 
Despite suppression of NF-kB activity having no significant effect on the 
recruitment of neutrophils to the PNC niche, close analysis of the behaviour of 
recruited neutrophils suggests short range recruitment mechanisms may be 
compromised. To inspect neutrophil migratory behaviour in detail, the acquired 
time lapse videos were further analysed using IMARIS software. This software 
allowed the tracking of individual neutrophils and provided a variety of 
measurements that captured neutrophil behaviour (Figure 4.6.2). Observation 
of the neutrophil tracks revealed recruited neutrophils often move between 
isolated PNC aggregates, but not all PNCs are persistently “visited” by these 
leucocytes. In fact, neutrophils are often attracted to a subset of PNCs where 
they exhibit a persistent concentrical migratory behaviour, such that, when 





Figure 4.6.2 Neutrophil track analysis reveals that inhibition of NF-kB signalling in the 
PNCs affects migratory behaviour of recruited neutrophils. A) Still image from a 3-hour 
long time lapse movie at 24hpi showing movement tracks of neutrophils recruited to PNCs in 
krtt1c19e:IkBSR transgenic larvae (bottom panel) and their WT siblings (top panel). The same 
tracks are then statistically coded according to (A right panel) mean speed, (C) mean distance 
to PNCs and (F) straightness index. Semi-automated analysis of neutrophil tracks with IMARIS 
software allowed quantification of distinct parameters such as: (B) neutrophil mean speed, 
(D,D’) neutrophil retention time, (E,E’) track mean distance to PNCs and (G,G’) track 
straightness index. Data acquired from 3 independent experiment; n=4 larvae per group 
(HRasG12V;WT= 110 tracks; HRasG12V; IkBSR= 91 tracks). (D) (E) (G) display neutrophil 
specific analysis. (B) (D’) (E’) (G’) display mean values per larva. Mean±SEM. Mann-Whitney 
test. (B) p>0.9999; (D) ***p=0.0003; (D’) p=0.1143; (E) **p=0.0035; (E’) p=0.0571; (G) 
p=0.6017; (G’) p=0.2000. Scale bar = 50 µm. 
 
it from multiple angles in interactions that can last several hours. During these 
interactions physical contact with the one PNC aggregate is not constant and 
neutrophils can momentarily move away from the PNCs but are almost 
immediately pulled back. (Figure 4.6.2 A, supplementary video 5).  
Suppression of NF-kB activity in PNCs seem to have attenuated this 
concentric behaviour. It is generally accepted that chemotactic gradients guide 
leukocytes to sites of their highest concentration by increasing their velocity 
and directionality [278,281]. Decreases in chemokine expression levels due to 
the suppression of NF-kB activity could affect the speed at which neutrophils 
were recruited to PNCs. However, no statistical difference was found (Figure 
4.6.2 A,B). Further analysis revealed, in a larval background with basal skin 
layer specific inhibition of NF-kB, that neutrophils displayed a lower retention 
time (maximum uninterrupted period of time spent “visiting” a specific PNC 
aggregate). Consequently, in this group, neutrophils exhibited shorter 
persistent tracks and were more often found moving from one PNC aggregate 
to the other as it is evident from the higher track mean distance to PNCs 
(Figure 4.6.2 C-E’). Considering the traits just mentioned, one would expect 
the neutrophil track straightness index, calculated as the ratio of track 
displacement length to track length, to be higher in larvae with a basal skin 
layer specific inhibition of NF-kB. However, no statistical difference was found 
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between the two conditions (Figure 4.6.2 F-G’). Nevertheless, one should 
remember that the inherently random nature of neutrophil movement, both  in 
the presence and absence of chemoattractants, often described as Brownian 
random walk [278], will introduce a high degree of variation within each group. 
Therefore, great mechanistic changes in short range neutrophil recruitment 




The role of NF-kB in tumour development is extremely complex. Depending 
on the type of tissue studied and the nature of the mechanism used to induce 
tumour formation, NF-kB was found to have both tumour promoting and 
tumour supressing effects. The study of this signalling pathway in skin 
carcinoma has resulted in especially contradictory findings, mainly due to its 
well-established role in the regulation of skin immune homeostasis [286,287]. 
The model here established presents a unique opportunity to follow, in real 
time, the early stages of tumour initiation and how the NF-kB signalling 
machinery is engaged to potentiate tumour promotion. Here, I show that 
overexpression of HRasG12V promotes rapid activation of NF-kB signalling in 
PNCs which enables rapid PNC turnover and mediates close neutrophil-PNC 
interaction. 
Using the NF-kB reporter transgenic line, where eGFP expression reads out 
NF-kB activity, NF-kB activity seems to be constitutively active from very early 
stages of preneoplastic cell emergence. The slow maturation time of eGFP, 
which could take a minimum of 2 hours, limits the temporal accuracy of this 
measurement. Nevertheless, given the cumulative nature of this reporter, the 
increasing trend from as early as the first timepoint analysed at 10hpi indicates 
the signalling pathway is already active. The early activation of NF-kB 
suggests it to be a direct downstream target of HRasG12V signalling. As a 
downstream effector of Ras signalling, the role of MAPK signalling in NF-kB 
activation was tested. However, suppression of this pathway through the 
treatment with the MEK inhibitor, Trametinib, showed no effect on NF-kB 
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activity. Nevertheless, other downstream effectors of Ras signalling have also 
been implicated in the activation of NF-kB. Ras was shown to promote direct 
IkBa phosphorylation and subsequent degradation via activation of PI3K-AKT 
signalling [117]. Other mechanisms include activation of RalGEF/RalB/Sec5 
and recruitment of the noncanonical kinase TANK-binding kinase 1 (TBK1) 
[121] and activation of PKCa and subsequent assembly of the CARMA1/3-
Bcl10-MALT1 complex [119]. Interestingly, PKCa was also shown to be 
upstream of IL-1a cytokine release contributing to the establishment of the 
autocrine loop through IL-1R-MyD88 pathway [130]. It should be noted, for the 
purposes of this study, zebrafish genome has only an ancestral version of the 
IL-1 gene, before expansion of the IL-1 locus into IL-1a, IL-1b and other 
members of IL-1 gene family. This zebrafish ancestral version contains higher 
homology to the mammalian IL-1b [306]. Nevertheless, zebrafish Il-1, which is 
also found upregulated from very early stages of PNC emergence (preliminary 
data by Nikolay Ogryzko, not shown), could be a plausible alternative in the 
establishment of this autocrine loop in our zebrafish model. However, it should 
be considered that the inactive pro-Il-1 requires a secondary stimulus, such as 
ATP, to be processed by the inflammasome and released [307]. Further 
activation of the NF-kB canonical pathway can be achieved via TLRs. In fact, 
carcinogen initiated inflammation in skin has been shown to depend on TLR4 
activation by the release of HMGB1 [308]. HMGB1 is a nuclear protein which 
is passively released during cell necrosis, but can also be actively secreted by 
inflammatory cells and cells under stress [309]. The observation of the 
upregulation of myd88 gene expression at a later stage of PNC development 
can also be indicative and sufficient for amplification of NF-kB signalling via its 
canonical pathway without requirement for external stimuli [100]. In agreement 
with these results, several studies with epithelial specific MyD88 knockout 
mice have demonstrated the requirement of MyD88 dependent signalling in 
intestinal, breast and skin tumour development [130,295]. However, the 
requirement for a long latency period before one can detect these lesions in 
murine models makes it impossible to attribute the requirement of MyD88 
dependent signalling to tumour initiation. Furthermore, MyD88 downstream 
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effects are not necessarily dependent on NF-kB transcriptional activity. MyD88 
was shown to amplify MAPK signalling by maintaining Erk in its active, 
phosphorylated form [293]. While MyD88 is also mechanistically involved in 
activation of AP1 transcription factor, in skin cancer its role in AP1 activation 
does not seem to be relevant [5]. Taking all this into consideration, the 
complexity with which RAS and NF-kB signalling are linked and the multitude 
of external signals that can further stimulate NF-kB activity indicate a more 
comprehensive study is required to understand the signals activating NF-kB in 
PNCs. 
Despite not being able to identify the main signal upstream of NF-kB activation, 
so far, the use of a basal layer keratinocyte specific IkBSR zebrafish 
transgenic line has allowed the study of how the suppression of the NF-kB 
signalling pathway affects PNC proliferation and neutrophil behaviour. The 
impaired PNC proliferative capacity observed in krtt1c19e:IkBSR larvae 
suggests that NF-kB has a pro-tumorigenic role in tumour initiation by 
promoting PNC proliferation, similar to what has been shown in a mouse model 
[129]. Several mechanisms can contribute to this effect. NF-kB can directly 
promote cell cycle progression via expression of CyclinD1 [310–312]. 
Furthermore, NF-kB stimulates the expression of c-Myc which can also 
promote cell proliferation [84].  
Additionally, NF-kB can promote proliferation by initiating a dedifferentiation 
program and promoting stemness. Oncogenic Ras transformed murine 
keratinocytes have been shown to escape terminal differentiation and 
consequent cell cycle arrest [313]. NF-kB signalling has been implicated in this 
mechanism by promoting downregulation of the gene expression of 
differentiation associated keratins as well as other genes characteristic of 
keratinocyte differentiation [130]. It is not yet known if this could be 
consequence of a direct effect of NF-kB mediated gene silencing or an 
autocrine effect of the pro-inflammatory phenotype. This ability to 
dedifferentiate and initiate a stem cell like signature expression profile is 
especially relevant during tumour initiation as it has been demonstrated in a 
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study of intestinal tumorigenesis. The study in question provided evidence that 
KRasG12D dependent activation of NF-kB signalling enhances b-catenin/Tcf-
mediated transcriptional activity leading to dedifferentiation of non-stem 
intestinal epithelial cells that acquire tumour-initiating abilities [314]. The 
consistent observation of a progressive decrease in PNC fluorescence from 
24hpi onwards (observational detail, data not shown) could be indicative of 
downregulation of keratinocyte specific genes driven by the initiation of a 
dedifferentiation program. However, a more comprehensive analysis of PNCs 
expression profile and its dependence on NF-kB activity is required. 
By promoting a pro-inflammatory environment with expression of pro-
tumorigenic cytokines, such as Il-1, NF-kB initiates an autocrine loop 
maintaining its activated state. Other inflammatory mediators, such as IL-6 and 
CXCL8, can also amplify other signalling pathways which also promote 
proliferation, such as STAT3 and MAPK [85,290]. 
The induction of a pro-inflammatory microenvironment through the activation 
of NF-kB signalling could also be a source of chemoattractants that promote 
the early neutrophil response seen in this model. Another model of skin early 
tumorigenesis has shown diminished neutrophil infiltration when NF-kB 
signalling is compromised [129]. However, this study revealed the basal layer 
keratinocyte specific suppression of NF-kB activity did not significantly affect 
neutrophil recruitment to the PNCs. Despite the small decrease (not 
statistically significant trend) in neutrophil infiltration, the observation that 
recruitment is still active suggests the existence of alternative alarmin signals 
which are not dependent on NF-kB activity. Several studies in zebrafish larvae 
point to hydrogen peroxide as a likely important signal for early neutrophil 
recruitment. Acute injury has been shown to generate a tissue-scale gradient 
of hydrogen peroxide by dual oxidase (Duox) [315]. Similarly, in a tumour 
initiation setting, HRasG12V transformed mucous secreting cells have been 
shown to generate Duox-mediated extracellular bursts of hydrogen peroxide 
[154]. Neutrophils are equipped with a redox sensor, Lyn, which, when 
activated by exposure to reactive oxygen species (ROS), drives neutrophil 
polarization and migration along hydrogen peroxide gradient [316,317]. 
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Consequently, abrogation of hydrogen peroxide production is often met with 
reduced neutrophil recruitment to wound and HRasG12V transformed cells 
[154,315]. Lipid mediators, such as Leukotriene B4 (LTB4), have also been 
implicated in neutrophil chemotaxis [318]. This leukotriene is often found 
elevated in HRasG12V transformed cells in vitro and blockage of its receptor, 
BLT2, suppresses tumour formation in vivo [319,320]. These signals, 
hydrogen peroxide and LTB4, can be rapidly produced and released in a NF-
kB independent manner, whereas chemokine release is usually slower due to 
regulation at the transcriptional and translational levels [318]. As such, if 
present in this model, they are likely to initiate the earliest neutrophil 
recruitments and promote subsequent release of chemokines which have 
longer half-life and the ability to act at longer distances. While the PNCs’ ability 
to produce chemokines may be compromised due to inhibition of NF-kB 
signalling activity in krtt1c19e:IkBSR transgenic larvae, recruited neutrophils 
maintain their ability to activate NF-kB signalling and downstream targets. 
These early signals can activate neutrophils to release cytokines and 
chemokines and, thus, amplify the inflammatory response [318]. 
Nevertheless, as evident in the more detailed analysis of neutrophil behaviour, 
NF-kB dependent signals derived from PNCs are important for short range 
neutrophil recruitment. In a wild type background neutrophils often exhibit a 
low directional persistent migration resembling neutrophil behaviour in other 
models of chronic inflammation [154,321]. This behaviour is consistent with 
the 2-fold manner Cxcl8 directs neutrophil migration. It has been shown 
that this chemokine establishes tissue-bound gradients by binding to heparan 
sulphate proteoglycans and modulates neutrophil recruitment by imposing a 
directional bias and triggering orthotaxis towards the source where it restricts 
neutrophil movement [278]. It is, then, very likely that Cxcl8 is the primary PNC-
derived chemokine promoting persistent neutrophil-PNC interaction. The loss 
of this persistent neutrophil-PNC interaction in the krtt1c19e:IkBSR larvae as 
it is evident by the lower retention time and higher mean distance to PNCs 
suggests NF-kB signalling is required for PNC retention signal. Considering 
the dichotomy with which Cxcl8 influences neutrophil migration, one can 
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understand why, despite these distinct behaviours, track straightness index 
remained unaffected. While qRT-PCR analysis (Chapter 3) confirms this 
chemokine expression is upregulated in PNC bearing larvae, further studies 
are required to verify its origin. Techniques such as cxcl8 in situ hybridization 
and qRT-PCR on FAC sorted PNCs from both, WT and krtt1c19e:IkBSR 
larvae, will greatly elucidate if Cxcl8 is the NF-kB dependent signal mediating 
persistent neutrophil-PNC interaction.  
Another mechanism that could be responsible for this less persistent neutrophil 
migration in krtt1c19e:IkBSR larvae is the release of DAMPs by dying cells. 
While the role of NF-kB signalling in cell death was not assessed in this model, 
it is generally understood that NF-kB can prevent DNA damage induced cell 
death with the expression of anti-apoptotic genes [129]. It is also known that 
in the face of two conflicting chemotactic signals, neutrophils prioritize newly 
arising or newly encountered attractants [322]. Therefore, in the absence of a 
retention force that keeps neutrophils interacting with a certain PNC 
aggregate, the death of a cell nearby can easily divert neutrophils from their 
original course. 
While these observations fit nicely with the possible importance of NF-kB-
Cxcl8 axis in neutrophil-PNC interaction, one cannot ignore that other 
chemokines may be involved. In fact, cxcl18b gene expression, which is also 
regulated by the MyD88-NF-kB pathway, was found to be upregulated in this 
model (Chapter 3). Cxcl18b can induce Cxcr2 dependent neutrophil 
recruitment, similarly to Cxcl8 [281]. However, whether these chemokines 
share other features, such as the mechanism of retention at the source, is not 
yet known. 
Moreover, the potential involvement of other inflammatory signalling pathways 
in the release of chemotactic signals cannot be ignored. A previous report 
established a connection between hydrogen peroxide and cxcl8 expression 
via AP1 transcriptional regulation in zebrafish wound response [323]. Even 
though it is likely this requires a persistent influx of hydrogen peroxide supplied 
by the wound gradient, which is not met in the stochastic and short-lived bursts 
transformed cells generate, it highlights the fact that the same pro-
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inflammatory genes can be regulated by several signalling pathways. 
Therefore, despite the well documented contribution of NF-kB signalling to the 
expression of these cytokines and chemokines, confirmation that their 
expression is compromised in krtt1c19e:IkBSR larvae is required. 
While this study allows for tissue specific suppression of NF-kB activity, a few 
limitations must be considered. The use of a UAS-regulated transgene as a 
stable transgenic line is susceptible to gene silencing due to methylation of the 
UAS promoter sequence. This gene silencing seems to be progressively more 
frequent from generation to generation [324,325]. Moreover, considering NF-
kB signalling regulates skin immune homeostasis, general suppression of its 
activity in both, PNCs and neighbouring cells, could potentially allow for a TNF 
mediated inflammatory response in PNC neighbours [142,144,287]. To 
overcome these limitations, a post-doctoral fellow in the laboratory, Nikolay 
Ogryzko, has generated a DNA construct in which a bidirectional UAS 
sequence controls both eGFP-HRasG12V and IkBSR transgenes 
(Supplementary Figure 7). Using this construct transiently, as per nature of this 
model, will allow us to avoid UAS silencing and restrict inhibition of NF-kB 
activity to PNCs. 
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5 Characterization of MyD88-NF-kB Signalling in Recruited 




Neutrophils constitute a great part of the inflammatory cells in the tumour 
microenvironment. However, until recently, their contribution to carcinogenesis 
and tumour development had been overlooked [146,147].  
Today, it is known that tumour associated neutrophils (TANs) can greatly 
influence several events of tumour development. With that influence 
dependent on their N1 or N2 polarization, they can have anti-tumorigenic or 
pro-tumorigenic functions, respectively [155]. Considering neutrophil 
phenotype is dependent on environmental factors, it has been suggested their 
polarization bias is correlated with the stage of tumorigenesis. TANs from early 
tumours were found to be more cytotoxic and produce higher levels of TNF, 
NO and H2O2. This effect was progressively reduced with tumour progression 
[157]. However, recent studies have shown a pro-tumorigenic role of 
neutrophils from an early neoplastic stage [149,150,154,160,161]. 
As inflammatory cells, neutrophils influence the tumour microenvironment by 
releasing cytokines to promote tumour associated inflammation [326], a 
process mainly dependent on the activation of NF-kB and selective MAPK 
pathways [327].  
However, contradictory results have arisen in the study of the role of NF-kB 
signalling in myeloid cells during tumorigenesis, suggesting it’s action to be 
organ and context dependent. While some studies demonstrated decreased 
tumour growth following abrogation of myeloid specific NF-kB signalling 
[135,328,329], others suggest NF-kB activity in these cells potentiate their anti-
tumorigenic phenotype [330–332]. It should be noted that these studies 
abrogate NF-kB signalling in the entire myeloid lineage, rather than specifically 
in neutrophils. It has been suggested the whole leucocyte population behaves 
in a similar manner as the neutrophil population, exhibiting comparable 
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expression of NF-kB responsive genes when activated with LPS [333]. 
However, the complexity of factors present in a tumour microenvironment and 
the heterogeneity of phenotypes observed within the same cell population 
indicate this approach in cancer studies may be overly simplistic.  
In this Chapter, I demonstrate that neutrophils exhibit an NF-kB dependent 
trophic role in PNCs and show evidence of heterogeneity within the neutrophil 
population. 
 
5.2 Detection of NF-kB Activity in Recruited Neutrophils 
 
Activated neutrophils can trigger the expression of many genes, including 
cytokines and chemokines, which contribute to the establishment of an 
inflammatory microenvironment. Many of these genes depend on the 
activation of the NF-kB pathway [327]. 
Using the NF-kB activity reporter zebrafish line previously introduced in 
Chapter 4, I tested whether neutrophils recruited to PNCs activated NF-kB 
signalling. However, the analysis of eGFP expression level in lyz:DsRed 
positive recruited neutrophils using live imaging was inconclusive. Live 
imaging of recruited neutrophils revealed that neutrophils maintained low 
levels of eGFP expression. When in close contact with PNCs, neutrophil eGFP 
intensity widely fluctuated, the high rate of which suggested that this was 
unlikely to be caused by NF-kB signalling activation (Figure 5.2.1). Similar 
occurrences were observed when neutrophils were in close contact with 
neuromasts or the lateral line, structures within the larval skin which display 
constitutive activation of NF-kB signalling, and therefore high EGFP intensity, 





Figure 5.2.1 Live imaging of PNC recruited neutrophils in an NF-kB reporter background 
is an inaccurate approach for the analysis of their NF-kB activation state. Still images of 
a time-lapse movie in a Tg(NFkB:eGFP) background with eGFP as a reporter of NF-kB 
activity. Neutrophils represented by surfaces, generated with IMARIS software, statistically 
coded for mean eGFP intensity showing that the neutrophil (follow neutrophil 1) GFP intensity 
fluctuates when in close contact with eGFP-HRasG12V PNCs due to automated neutrophil 
fluorescent intensity based segmentation defining PNC GFP fluorescence as within a 
neutrophil. Scale bar = 50 µm. 
 
Considering the automated neutrophil segmentation is based on DsRed 
fluorescence intensity, the image analysis software, IMARIS, may include 
some of the neighbouring eGFP fluorescence as within the neutrophils. As 
such, it is possible, while in close contact with cells exhibiting high levels of 
eGFP expression, the neutrophils eGFP intensity variation was an artefact 
caused by the inclusion of some of these cells fluorescence as within the 
neutrophil. Given the low basal levels of NF-kB activity in the neutrophils 
compared to other cells within the skin, with which recruited neutrophils often 
closely interact, live imaging was an impractical approach for proper analysis 
of NF-kB activity in neutrophils. 
As it seemed that proximity to PNCs and high levels of eGFP intensity in other 
cell types within the larval skin were an impediment to analysis of neutrophil 
NF-kB activity, the isolation and analysis of lyz:DsRed positive neutrophils by 
flow cytometry was a potential alternative. 
Triple transgenic (krt4:eGFP-CAAX/HRasG12V; NFkB:eGFP; lyz:DsRed) larvae 
were dissociated at 24hpi and the GFP intensity of DsRed positive neutrophils 
was assessed as a read-out of NF-kB activation (Figure 5.2.2 A, gating 
strategy in Supplementary Figure 4). Larvae with CAAX control cells displayed 
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only 0.5% eGFP positive neutrophils with a low level of mean intensity. PNC 
bearing larvae displayed a slightly higher, but not statistically significant, 
proportion of neutrophils with NF-kB activity. In the HRasG12V condition 1.5% 
of lyz:DsRed positive neutrophils were eGFP positive with higher levels of 
mean intensity (Figure 5.2.2 B, C). 
Considering the evident trend, the lack of statistical significance may be due 
to the small size of the sample.  This experiment, should, then, be repeated a 
few more times to generate more powerful statistics. 
Considering the cumulative nature of this reporter, low levels of eGFP 
intensity, observed in the CAAX condition, could indicate that the NF-kB 
signalling pathway hadn’t been activated for long. Therefore, this small 
population of presumably recently activated neutrophils could be a result of the 
dissociation process. Note that the entire process of sample preparation takes 
nearly 2 hours, in which larvae dissociation is achieved with the combination 
of both enzymatic and mechanical forces and lasts for nearly 30 minutes at 
28.5oC. In PNC bearing larvae, the higher levels of mean eGFP intensity 
detected in eGFP/DsRed double positive neutrophils could then be the result 
of longer activation period (Figure 5.2.2 B,C). These results could also indicate 
a difference in the level of NF-kB activation, with PNC bearing larvae having a 




Figure 5.2.2 Flow cytometry analysis of lyz:DsRed+ neutrophils showed a small 
population of neutrophils with NF-kB activity A) Representative Scatter dot plots from flow 
cytometry analysis of DsRed positive neutrophils in CAAX control and PNCs bearing larvae in 
an  NF-kB reporter background at 24hpi. The vertical line across the plot denotes the threshold 
used to distinguish between NF-kB positive and NF-kB negative cells. B) Proportion of DsRed 
positive cells which are eGFP positive. C) eGFP mean intensity of eGFP/DsRed double 
positive cells. Data acquired from 3 independent experiments (n=3). Mean±SEM. Mann-
Whitney test. ns p=0.1000  
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5.3 NF-kB Activity Inhibition in Neutrophils Affects PNC Proliferation 
 
Neutrophils have been shown to promote tumour growth and studies of tumour 
initiation have suggested the pro-tumorigenic effect of recruited neutrophils is 
relevant from early stages of tumour development [149,150,154,160,161]. As 
a pathway promoting the inflammatory response from activated neutrophils, 
NF-kB transcription factors could potentially regulate the mechanisms through 
which neutrophils promote proliferation of tumour cells. 
To assess the effect of neutrophil specific NF-kB signalling in PNC 
progression,  I used a transgenic line that allows for neutrophil specific 
suppression of this signalling pathway. Lineage specific suppression of NF-kB 
activity was achieved with expression of the constitutively active dominant 
negative mutant form of the murine IkBa, IkBSR, now under the control of the 
neutrophil specific promoter lyz [199]. This mutant IkBa is resistant to 
phosphorylation and consequent proteasome degradation [302,303]. It should 
be noted that while in most cell types NF-kB activation is regulated by the 
nuclear translocation of its subunits, in neutrophils, IkBa is present in both, 
cytoplasm and nucleus, and NF-kB activation correlates with a substantial 
reduction of this protein in both cell compartments [334]. As IkBa has great 
functional and structural similarities between teleosts and mammals, IkBSR 
has also been shown to inhibit NF-kB signalling in zebrafish embryos 
[304,305]. 
The Tg(lyz:IkBSR) zebrafish transgenic line was made using Tol2-
transposase-mediated transgenesis [202] by another member of the Feng 
Laboratory. The active expression of the transgene was confirmed by RT-PCR 
on total RNA extracted from whole larvae. Comparison of larvae carrying the 
cry:CFP (blue retina) selection marker with WT siblings showed successful 
integration and expression of both, the selection marker and transgene (Figure 
5.3.1 A).  
To determine the effect of neutrophil-specific inhibition of NF-kB signalling on 
PNC proliferation, I crossed Tg(lyz:IkBSR) with Tg(krtt1c19e:KalTA4-ERT2) 
 95 
and used EdU incorporation to study PNC proliferative capacity. Suppression 
of NF-kB signalling in neutrophils is associated with a significantly lower PNC 
proliferative capacity at 24hpi. While in a WT background »37% of PNCs were 
detected as actively dividing at 24hpi, only »19% of PNCs exhibited 
proliferative capacity when NF-kB signalling in neutrophils was suppressed 
(Figure 5.3.1 B). Therefore, NF-kB signalling is likely to be, at least in part, a 





Figure 5.3.1 Neutrophil specific NF-kB activity inhibition affects PNC proliferative 
capacity A) RT-PCR on total RNA extracted from whole larvae showing larvae positive for the 
cry:CFP (blue retina) selection marker from the lyz:IkBSR zebrafish transgenic line efficiently 
express the transgene in comparison to their WT siblings with no selection marker. 
Peptidylprolyl isomerase A (PPIA) is used as a housekeeping gene to assure comparable 
overall gene expression levels (performed by Nikolay Ogryzko). B) Percentage of proliferating 
PNCs in lyz:IkBSR transgenic larvae and their WT siblings at 24hpi. Quantification of double 
positive cells following EdU detection and eGFP/HRas immunostaining was performed by 
optical sectioning. Data acquired from 2 independent experiments; n³ 12 per group. 






5.4 Neutrophils with Different Levels of MyD88 Expression Exhibit 
Different Recruitment Behaviour 
 
As it has been discussed previously, MyD88 is crucial for initiating signalling 
responses to IL-1β and other cytokines [99]. Therefore, leucocytes and tissues 
where these cells originate display a high basal level of MYD88 gene 
expression [208,335]. Moreover, MYD88 gene expression can be further 
upregulated in a variety of immune cells by several pro-inflammatory mediators 
such as, IL-6 [335], LTB4 [336,337], IFN-a and IL-12 [338]. Following the initial 
observation that emerging preneoplastic cells induce an inflammatory 
response, I hypothesised that myd88 expression in neutrophils changed in the 
early stages of tumour initiation. 
Similarly to previous experiments, the Tg(myd88:DsRed2) reporter line [208] 
was used to study myd88 expression levels in neutrophils. As the MyD88 
reporter controls a DsRed transgene, using eGFP-HRasG12V necessitated the 
development of a neutrophil reporter line with a distinct fluorophore to enable 
this experiment. In the newly generated transgenic line, neutrophils express 
lifeact-mTurquoise2a under the control of the neutrophil specific lyz promoter 
[199]. Lifeact is a peptide, containing the first 17 amino acids of the actin-
binding domain, Abp140, present in Saccharomyces cerevisiae, which targets 
the fluorophore to bind F-actin filaments in the cytoskeleton [339]. Initially 
tested in mammalian cells, this peptide has been successfully used to label 
actin filaments in zebrafish larvae [340,341]. While particularly advantageous 
for studies of actin dynamics and cell polarity, this feature was not explored in 
the following studies.  
Taking a whole embryo approach, with flow cytometry analysis, triple 
transgenic (krtt1c19e:eGFP-CAAX/HRasG12V; myd88:DsRed; lyz:lifeact-
mTurquoise2a) larvae were dissociated at 24hpi and mTurquoise2a positive 
neutrophils were assessed for their DsRed fluorescent level as a read-out of 
myd88 gene expression level (gating strategy in Supplementary Figure 5). 
Both, CAAX control and HRasG12V, conditions displayed a wide range of 
DsRed intensity levels within mTurquoise2a positive neutrophils (Figure 5.3.1 
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A). Similarly to what had been suggested in a previous report [208], 
approximately 80% of neutrophils displayed some level of DsRed expression, 
and consequently myd88 promoter activity (Figure 5.3.1 A,B). This proportion 
was also found in PNC bearing larvae which showed no evidence of myd88 





Figure 5.3.1 Flow cytometry of lyz:lifeact-mTurquoise2a+ neutrophils showed myd88 
gene expression is not affected in PNC bearing larvae A) Representative histogram from 
flow cytometry analysis of mTturquoise2a positive neutrophils according to DsRed intensity 
levels, in CAAX control and PNCs bearing larvae at 24hpi. Cell Count on the Y axis and DsRed 
fluorescence intensity on the X axis. B) Proportion of mTurquoise2a positive neutrophils with 
different levels of myd88 gene expression categorised as depicted in (A). Data acquired from 
3 independent experiments (n =3). Mean±SEM. 2 Way ANOVA with Sidak’s post-test. ns 
p³0.9837 
 
Given the wide range of DsRed intensity levels within the neutrophil 
population, I decided to evaluate the potential of neutrophils with different 
levels of myd88 promoter activity to contribute to the inflammatory response 
induced by the emergence of PNCs. 
Live time-lapse imaging of triple transgenic larvae at 24hpi suggested all 
neutrophil subsets contribute to an inflammatory response as various levels of 





Figure 5.3.2 myd88 and lyz expression levels seem to be negatively correlated. A) Still 
image of a time lapse movie showing recruited neutrophils displaying different levels of DsRed 
intensity as a readout for myd88 gene expression. A’) Examples of neutrophils from (A) with 
separated colour channels for better visualization of negative correlation between mTurquoise 
and DsRed intensity. B-C) Neutrophils recruited within a 2-hour time lapse movie at 24hpi 
according to their mTurquoise (Y axis) and DsRed (X axis) mean intensity. Scatter plot of 
individual neutrophils (B) and linear regression estimate (C) where each colour represents an 
individual larvae. To account for variation due to differences in transgene copy number, mean 
intensity values of each neutrophil were normalized to average intensity of all neutrophils 
within each larva. Consequently, plotted values represent relative intensity where X/Y=1 
represents the neutrophil average intensity within each larva. Dashed line at X=1 in (B) 
represents the value separating the two neutrophil subsets compared in the subsequent 
analysis of migratory behaviour. Data acquired from 3 independent experiments. n=5. 




5.3.2 A, A’, Supplementary video 6). Interestingly, when intensity values for 
DsRed and mTurquoise are plotted for each individual neutrophil recruited to 
the skin, a negative correlation between them was evident. Neutrophils with 
high mTurquoise intensity levels, indicating high lyz promoter activity, would 
often show low DsRed intensity, indicating low myd88 promoter activity. On 
the contrary, neutrophils with low mTurquoise intensity levels would 
preferentially display high DsRed intensity (Figure 5.3.2 B,C).  
While these results show a strong negative correlation between mTurquoise 
and DsRed expression, the bias introduced by the approach used to identify 
leucocytes should be considered. Neutrophils were identified by lyz promoter 
activity and automated detection by the image analysis software, IMARIS, 
which is dependent on the fluorescent intensity of either, mTurquoise or 
DsRed. A few neutrophils with low intensity levels for both fluorophores were 
observed being recruited to PNCs, however as they fell below the detection 
threshold for IMARIS they are missing from the analysis, presenting a possible 
source of error. 
Following the observation that the neutrophil population being recruited to the 
skin had highly heterogenous myd88 gene expression. I wanted to study if 
these transcriptionally distinct neutrophils would also exhibit distinct 
behavioural patterns when interacting with PNCs. 
Given the great variety of DsRed and mTurquoise intensity values of recruited 
neutrophils, there is no distinct separation of neutrophil subsets with regards 
to these parameters (Figure 5.3.2 B). With no other characteristic available, an 
arbitrary division at the average neutrophil DsRed intensity was used to 
separate the recruited neutrophils into two subsets. As such, neutrophils with 
relative DsRed intensity lower than 1 were grouped into the MyD88low 
neutrophil subset, and neutrophils with relative DsRed intensity higher than 1 
were grouped into the MyD88high neutrophil subset (Figure 5.3.2 B). 
Once again, time-lapse videos were analysed using the tools provided  by the 
IMARIS software package. Using this image analysis software, individual 
neutrophils were tracked and their recruitment, persistence and close 
interactions with PNCs were assessed. Speed while in contact with PNCs and 
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retention time, measured as maximum uninterrupted period of time spent 
“visiting” a specific PNC aggregate (Figure 5.3.3) were analysed. When 
comparing the two neutrophil subsets, MyD88low neutrophils behaved more 
similarly to what had been described in the previous chapter. These 
neutrophils remained in close proximity with PNCs for the majority of the time, 
exhibiting persistent tracks around distinct PNC aggregates where they exhibit 
low mobility range as depicted by their low speed. On the contrary, MyD88high 
neutrophils displayed a wider array of tracks not restricted to PNC rich areas 
(Figure 5.3.3 A). This is likely to be consequence of their inability to be retained 
by and interact closely with PNCs, as suggested by their high speed and low 
retention time in comparison to MyD88low neutrophils (Figure 5.3.3 B-C’). 
As mentioned before, while the differences in migratory behaviour are evident, 
the chosen method for the separation of the two population subsets may not 
be accurate. Considering that neutrophil MyD88-dependent signalling is 
unlikely to directly affect their migratory behaviour, the concurrence of 
consistent levels of myd88 expression and behavioural pattern within each 
group may not be related. A more comprehensive characterization of these 
neutrophils, with regards to differences in expression of surface receptors, will 
greatly contribute to more accurately define population of cells and a better 





Figure 5.3.3 Neutrophils with different levels of myd88 expression exhibit different 
recruitment behaviour. A) Still image from a 2-hour long time lapse movie at 24hpi showing 
movement tracks of MyD88low neutrophils (left panel) and MyD88high neutrophils (right panel) 
recruited to PNCs. Tracks are statistically coded according to track mean speed. Semi-
automated analysis of neutrophil tracks with IMARIS software allowed comparison of the two 
neutrophil subsets according to distinct parameters such as: neutrophil speed (B,B’) and 
retention time (C,C’). Data acquired from 3 independent experiment; n=5 larvae (MyD88low 
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Figure 5.3.3 (continued) neutrophils= 57 tracks; MyD88high neutrophils= 48 tracks). (B) (C) 
display neutrophil specific analysis. Mean±SEM. Unpaired Student t test. (B’) (C’) display 
group mean values per larva. Mean±SEM. Paired Student t test. (B,B’) **p= 0.0097; 




Oncogene transformed cells have been shown to elicit a prompt neutrophilic 
inflammatory response [149,150,154,160,206]. Therefore, neutrophils have 
the potential to affect tumour development from the initiation stage. Identifying 
their effector mechanisms and how they influence tumour cells is of extreme 
importance for a better understanding of the events that drive tumour 
progression. Considering the central role of NF-kB activity in the regulation of 
inflammatory genes, here I studied the ability of PNC recruited neutrophils to 
activate NF-kB and explored the role of this signalling pathway in neutrophil 
mediated PNC proliferation. 
While the NF-kB reporter transgenic line had been previously useful in the 
characterization of NF-kB activity in PNCs, detection of this signalling pathway 
activity in neutrophils faced some issues. Live imaging of recruited neutrophils 
was impractical due to the higher levels of eGFP expression in cells within the 
skin with which neutrophils would regularly and persistently interact. Trying to 
overcome this limitation, flow cytometry analysis of dissociated larvae allowed 
the assessment of NF-kB activity in individual neutrophils. However, this 
approach only detected of a very small population of neutrophils with NF-kB 
activity. Many studies have already demonstrated the central role NF-kB 
activity in the regulation of inflammatory genes in neutrophils 
[327,333,334,342]. Additionally, it has been previously suggested that 
continuously stimulated neutrophils, as it should be  the case in this model of 
tumour initiation, maintain persistent NF-kB activity despite considerable 
levels of IkBa present in the nucleus [343]. Given the small proportion of eGFP 
positive neutrophils detected, one could argue that NF-kB activity is not 
biologically significant for neutrophil function in this model of tumour initiation. 
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Nevertheless, with NF-kB playing such a central role in neutrophil biology, one 
should first consider the possibility of poor sensitivity of the transgenic reporter 
in neutrophils. For instance, while all NF-kB subunits have the ability to bind 
the consensus recognition sequence, distinct NF-kB dimers do so with 
different affinities [90]. Moreover, activation of distinct dimers is the main factor 
allowing selective regulation of NF-kB target genes [90]. As such, depending 
on the dimers preferentially formed in recruited neutrophils this transgenic line 
may not be an accurate reporter for NF-kB activity in neutrophils. 
Considering the high sensitivity of activated neutrophils to shear stress 
[344,345], it is also possible the mechanic forces in place during the process 
of cell dissociation induced some degree of neutrophil apoptosis, resulting on 
the loss of the cells of interest. 
Despite not conclusively demonstrating NF-kB activation in recruited 
neutrophils, the use of a neutrophil specific IkBSR zebrafish transgenic line 
has confirmed that this signalling pathway is, in fact, active. The impaired PNC 
proliferative capacity observed in Tg(lyz:IkBSR) larvae suggests neutrophils 
exhibit a tumour promoting role in tumour initiation which is, at least in part, 
dependent on NF-kB activation. This is consistent with previous reports 
showing that myeloid specific IKKb ablation causes decreased proliferation in  
early tumour development in both inflammation and oncogene induced 
carcinogenesis [328,329]. According to these studies, the main mechanism by 
which myeloid cells promote tumour growth in an  NF-kB dependent manner 
is with transcriptional activation of pro-inflammatory cytokines and chemokines 
such as, IL-1b, IL-6 and CXCL8, which activate proliferation promoting 
signalling pathways  within tumour cells [328,329]. COX2 expression level is 
also compromised in myeloid cells following IKKb ablation [328]. This enzyme 
is required for  prostaglandin E2 (PGE2) synthesis [320]. Neutrophils and other 
leucocytes have been shown to be the main sources of this eicosanoid, which 
promotes tumour cell proliferation [161,244,346]. Myeloid derived MMP9, 
another known NF-kB target, has also been implicated in proliferation of 
neoplastic lesions. In a murine transgenic model of skin tumorigenesis elicited 
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by a HPV16 oncogene, the reduced keratinocyte proliferation observed in 
Mmp9 knockout mice was restored when irradiated mice were transplanted 
with bone-marrow from WT mice [163]. mmp9 expression is also upregulated 
in our tumour initiation model (Chapter 3). But, while in this study it is not clear 
which cell types within the PNC microenvironment contribute to this effect, 
other studies suggest a predominant contribution from neutrophils 
[150,163,347]. 
Further studies are needed to elucidate the relevance of each of these factors 
in the NF-kB dependent, neutrophil trophic role observed in this model. 
It is also evident, from these results, that recruited neutrophils comprise a 
heterogeneous population with distinct migratory behaviours. With the 
available tools, two populations were defined according to their myd88 gene 
expression level. MyD88low neutrophils with high levels of lyz promoter activity 
displayed a close and persistent interaction with PNCs, consistent with the 
previous neutrophil behaviour analysis in Chapter 4. Additionally, a distinct 
MyD88high neutrophil subset with low levels of lyz promoter activity was 
identified having a less persistent, more widespread movement. 
The results obtained here are not sufficient to identify, with certainty, the origin 
of this neutrophil subset. Nevertheless, the continuous high to low spectrum of 
mTurquoise intensity suggests that, rather than being a distinct population, 
these are immature neutrophils at various stages of development. 
Previous studies have demonstrated the presence of a small population of 
immature granulocytes in the tumour microenvironment [348–350]. These 
cells are believed to originate from the activation of an emergency granulocytic 
differentiation program in circulating and bone marrow-derived hematopoietic 
stem and progenitor cells (HSPCs). This mechanism is driven by tumour 
derived cytokines and growth factors, such as, IL-6 and granulocyte-colony 
stimulating factor (G-CSF) [351–353]. Gene expression analysis showed 
immature granulocytes displayed low levels of chemokine receptors CXCR1 
and CXCR2 when compared to fully matured neutrophils, and, consequently 
decreased chemotaxis towards the tumour signals [349,354]. Consequently, 
during early tumour progression, these cells are most commonly found 
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accumulated in the peripheral tissues but not within the primary tumour 
[349,352]. While the presence, or rather, the lack of these receptors in the 
MyD88high neutrophils needs further analysis, that could explain their inability 
to form long lasting interactions with PNCs as it is evident by their track pattern 
and low retention time.  
Given their immature myeloid characteristics these immature granulocytes are 
often considered as part of the heterogeneous population of myeloid derived 
suppressor cells (MDSCs). However, several independent studies showed 
that, contrary to what is observed in late stages of cancer,  during early tumour 
progression, these cells do not exhibit immunosuppressive activity 
[350,354,355]. Additionally , these immature granulocytes displayed higher 
metabolic activity and ATP production, which were correlated with enhanced 
spontaneous migration [354]. Despite the role of immature granulocytes in 
early tumour development is still unclear, they have been suggested, due to 
their enhanced spontaneous migration, as mediators of early tumour cell 
dissemination [354]. Given the difference observed in the speed of the two 
populations, it would be interesting to test whether the high velocity of 
MyD88high neutrophils is also regulated by an ATP mediated autocrine loop 
[354,356].  
While these observations are correlative rather than causative, they provide a 
future direction of how to move forward to identify and better characterize this 
neutrophil subset. By understanding what defines this subset and how it is 
recruited to the PNCs I could potentially manipulate their effect in the PNC 
microenvironment to determine their mechanism of action in tumour initiation.  
Given their high level of myd88 expression, it would also be interesting to know 








6 Final Discussion 
 
Tumour development is a multi-stage process initiated by one or more somatic 
cells possessing genetic alterations which confer them proliferative advantage 
and invasive properties. These events are powered by both intrinsic 
mechanisms and by the microenvironment of the transformed cells.  
Modelling such complex disease using experimental organisms provides an 
unprecedented opportunity to study tumour initiating events from the 
perspective of all responsible cells and signalling pathways to identify potential 
targets in preclinical studies for early detection and preventive therapies [357]. 
 
6.1 Establishment of a New Zebrafish Model for the Study of Tumour 
Initiation 
 
 As part of this project, a model of epithelial tumour initiation in zebrafish larval 
skin was developed. This model uses tissue specific, mosaic over-expression 
of the HRasG12V oncogene to drive tumour initiation. While one cannot identify, 
with certainty, the driving oncogene which initiated tumorigenesis in 
spontaneously developed tumours, increasing evidence places uncontrolled 
Ras signalling amongst the earliest events. Ras gene mutations are an early 
and frequently detected event in tumour lesions. Activating Ras mutations are 
amongst the most common tumour drivers, present in approximately one third 
of all human cancers [46]. Epigenetic alterations leading to constitutively active 
Ras signalling are even more frequent in skin cancer [130,358]. A great 
number of studies have previously shown the potential of oncogenic HRas and 
KRas to promote hyperplasia and tumour formation in transgenic mice and 
zebrafish models [160,172,174,213,228–231,357,359]. Therefore, 
understanding the consequences of the activation of Ras signalling is of 
extreme importance for understanding early tumorigenesis. 
 The inducible zebrafish PNC model with temporal and spatial control of 
oncogene expression allowed the early detection and study of PNC 
emergence and of the first events that initiate the process of tumour 
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development. Early work for this project comprised detailed observational 
studies of PNC phenotype progression and initial characterisation of the 
model. Analysis of PNC development allowed the observation of progressive 
cell morphology and behaviour alterations, vastly  recognised as consequence 
of oncogene transformation. As such, PNCs exhibited increasing proliferation, 
epithelial cell plasticity and motility, DNA damage and cell death, in agreement 
with features of naturally occurring preneoplastic lesions. 
Even though not immediately evident, PNCs developed into heterogeneous 
populations with distinct morphologies and behaviour. While some cells 
exhibited a round morphology, others developed a more elongated shape, 
presumably as a result of a more interactive behaviour.  Given the multitude 
of downstream effectors of Ras signalling and their specific effect on distinct 
cellular mechanisms [24,66], it is possible that different cells exhibit distinct 
signalling networks, depending on the activation of a selective fraction of 
downstream effectors, which may be responsible for the heterogeneous PNC 
phenotype. However, the mechanisms whereby specific Ras effector 
pathways are preferentially activated are still poorly understood. Nevertheless, 
one cannot ignore the additional variability introduced by the transient 
approach for generating PNCs in this model, as cells can carry varying 
numbers of oncogene copies. Therefore, each larva often exhibits a PNC 
population with heterogeneous HRasG12V expression levels. Considering that 
Ras downstream signalling networks, the final signal output and, ultimately, 
the determination of a cell’s fate can be greatly influenced by the intensity and 
duration of HRas signalling activity [24,31], it is likely that the variation in 
HRasG12V expression levels is partially driving PNC heterogeneity. 
The possibility of inserting multiple copies of the HRas oncogene introduces 
an additional concern. As one would logically deduce, high oncogene copy 
number increases the aggressiveness of a transformed cell’s phenotype 
[24,299,360]. Additionally, mutant allele copy gain is a well-documented 
required event for the progression to papilloma stage of tumour development 
[213,361]. Therefore, it is possible that some of the PNCs produced in this 
model develop a strong phenotype which does not mimic spontaneously arisen 
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preneoplastic lesions. Nevertheless, a stronger phenotype may speed up PNC 
progression allowing the succession of events which would naturally occur 
during the course of several years to be studied within an experimentally 
feasible timeline.  
It should be noted that the very same features that allow for temporal and 
spatial resolution, limit the scope of this model to early stages of 
tumorigenesis. The design of this model requires constant treatment with 4-
OHT for continuous expression of the oncogene. Given that long term 
treatment with 4-OHT is detrimental to normal zebrafish development and 
health, there is a limit as to how long it is possible to follow PNC progression 
without avoiding the adverse effects of this drug. Additionally, the oncogene is 
under the control of a keratinocyte specific promoter. Tumour progression is 
often associated with the alteration of cell fate decisions, as tumour cells 
develop plasticity and stemness [23,362]. As such, it is possible that oncogene 
expression is eventually silenced at later stages. In fact, progressive decrease 
in PNC fluorescence from 24hpi onwards was consistently observed 
throughout the project.  
Taking all these limitations into account, a new improved mechanism for the 
generation of PNCs is currently under development in the Feng Laboratory. 
Nevertheless, the current model can be used to study many aspects of tumour 
initiation. As mentioned in this thesis, this model offers a platform for the study 
of cell competition, PNC plasticity, PNC survival and oncogene induced 
inflammation. Other aspects of tumour initiation, not mentioned here, but being 
explored by other members in the Feng Laboratory are mitochondrial and 
metabolic alterations, and oncogene-induced senescence. 
 
6.2 Linking NF-kB with Tumour Promotion at Early Stages of Tumour 
Development 
 
Following the observation of a strong inflammatory response to early stages 
of PNC emergence I set out to study the role of the NF-kB signalling pathway 
in the early stages of tumour development. 
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This model showed that PNCs promote a strong early activation of NF-kB 
signalling, however, the mechanisms for its activation are not yet fully 
elucidated. 
From this study it is evident that NF-kB activity has an important role in PNC 
clonal expansion. Suppression of NF-kB activity in both PNCs and neutrophils, 
led to a lower proportion of proliferating cells. There are several mechanisms 
whereby NF-kB signalling can promote, either intrinsically or through paracrine 
effects, PNC proliferation and they have been discussed previously. To 
understand the importance of each of these mechanisms in this model, 
however, further studies blocking specific NF-kB dependent signals, are 
required. Nevertheless, globally, this effect strongly suggests that NF-kB 
activity is extremely important for the early stages of tumour promotion.  
As it is evident in this study PNCs sustain increasing amounts of DNA damage. 
Previous studies have provided evidence that oncogene activation generates 
replicative stress, causing high incidence of DSBs [246]. DNA breaks often 
trigger a DNA damage response and p53-dependent cell cycle arrest, 
apoptosis or senescence, halting tumour progression [12,246,248]. 
Conversely, they also potentiate genomic instability and lead to deleterious 
mutations of critical tumour suppressor genes inactivating the DNA damage 
response and promoting tumour progression [12,248,258,259]. By stimulating 
DNA damaged cells to enter the cell cycle, NF-kB signalling can contribute to 
this effect by generating sequence rearrangements and point mutations which 
will be transmitted to daughter cells [80–82]. Therefore, NF-kB activation can 
increase the number of DNA damaged cells that accumulate oncogenic and 
tumour suppressor gene mutations, mediating progression of tumour 
development [85]. 
A related, well characterized, NF-kB mechanism of action, that is yet to be 
confirmed in this model, is its role in PNC survival [85,129,288], as well as the 
mutual antagonism of NF-kB and p53 activation [88,363]. As pre-cancerous 
lesions are often associated with a high incidence of apoptosis and 
senescence due to a p53-dependent response, it would be interesting to 
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evaluate the role of NF-kB in PNC survival and verify if its activation can 
contribute to PNC evasion of oncogene-induced senescence. 
While the role of NF-kB in PNC proliferation is well established, the importance 
of this signalling pathway in establishing an inflammatory microenvironment is 
less evident. Analysis of neutrophil migratory behaviour allowed the finding 
that basal skin cell layer specific NF-kB inhibition affects neutrophil retention 
at the PNC areas but has little effect on its recruitment. This is inconsistent 
with a previous study showing considerably lower myeloid cell infiltration in 
mice with p65-/- tumour cells when compared to mice with WT tumour cells 
[129]. While the analysis shown here may be considerably underpowered, the 
different techniques used in the two studies may also be responsible for the 
contradictory results. Namely, the use of different model organisms and the 
mechanism for oncogenic Ras transformation: here I used oncogene 
transgenesis, contrary to the DMBA/TPA-induced carcinogenesis in the other 
report. A recent study has shown NF-kB signalling in different cell 
compartments of tumour microenvironment contribute differently for early 
tumour promotion. While tumour cell derived signalling enhanced epithelial 
turnover, myeloid cells contributed to  production of tumour and stemness 
enhancing cytokines [135]. The report corroborates the findings described 
here. Nevertheless, further analysis of inflammatory cytokine and chemokine 
expression in both basal skin cell layer and neutrophil specific IkBSR needs to 
be done for a better understanding of these findings. With this analysis, 
identification of the PNC derived signal/s which promote close PNC-neutrophil 
interaction may also be possible. 
As mentioned before, these issues will also be reassessed in a PNC specific 
IkBSR background for confirmation that the effects here observed are the 
consequence of PNC intrinsic NF-kB suppression. 
Although not discussed here, the contribution of macrophages to tumour 
development is well established. Preliminary data have shown that PNCs also 
elicit a macrophage inflammatory response (data not shown), however the 
study of recruited macrophages in PNC progression has only recently been of 
interest in the Feng Laboratory. Considering previous reports, suggesting 
 111 
tumour cells specific NF-kB activity is important for tumour evasion of immune 
surveillance by supressing macrophage cytotoxicity [288,291,364], it would be 
interesting to test if PNCs in this model exhibit a similar behaviour. Future 
directions will also involve the study of the effect of macrophage specific NF-
kB suppression on PNC proliferation and ultimately early tumour development. 
The regulatory effect of NF-kB in PNC progression was evaluated using IkBSR 
as a suppressive mechanism. Even though IkBSR is widely used as a tool for 
inhibition of NF-kB activity, one has to consider the secondary consequences 
of over-expressing this protein. Since IkBa does not bind to all NF-kB subunits 
with the same affinity, IkBSR over-expression is likely to have an effect on the 
availability of different dimers and direct gene expression in an unclear way 
[365]. IkBSR could also mediate carcinogenesis in an NF-kB independent 
way. Several reports have shown IkBa can bind promoter sequences directly 
and regulate gene expression of Notch target  genes [366] and Polycomb 
target genes [367] controlling differentiation and cancer in keratinocytes. 
 
6.3 A Potential Model for the Study of Immature Granulocytes in 
Tumorigenesis 
 
While studying neutrophil recruitment a new subset of neutrophils was 
observed being recruited to PNCs. These neutrophils exhibited a distinct 
behaviour from what had been observed previously, moving at a higher speed 
and lower capacity to be retained in contact with PNCs. The newly found 
subset of neutrophils had a characteristic decreased transcriptional activity of 
the neutrophil marker and was defined as Myd88high Lyzlow. Therefore, they 
were hypothesised to be immature granulocytes. While a more detailed 
characterization of this neutrophil subset is necessary, the analysis of their 
behaviour corroborates their presumed origin. Immature granulocytes are 
often found  in circulation in tumour patients [348–350]. These cells are of 
particular interest as they are believed to support tumour dissemination by 
migrating to distant sites away from inflammation to mediate tumour spread 
[365]. They are also believed to mature at later stages of tumorigenesis into 
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MDSCs [349,350,352,354,355]. The study of the mechanisms that promote 
the premature release of immature granulocytes from the CHT and the 
chemotactic  signals they respond to, as well as their effect on tumour 
promotion need to be addressed for a better understanding of the role of these 
cells in tumorigenesis.  
 
6.4 Final Conclusion 
 
Due to the limited availability of suitable platforms for the study of tumour 
initiation, the Feng Laboratory developed a new in vivo zebrafish model. The 
model, here characterized, allows for a non-invasive approach for the early 
detection of PNCs in vivo and the study of their interactions with the 
surrounding tissues. For the purposes of this project, I used this model to study 
the onset of an inflammatory microenvironment during PNC progression and 
the role of NF-kB as a potential regulator of inflammation. I was able to detect 
early activation of NF-kB signalling in PNCs and demonstrate its importance 
in PNC proliferation and promotion of an intimate interaction with recruited 
neutrophils. According to these results, recruited neutrophils also exhibit a 
trophic effect which is, at least partially, dependent on NF-kB signalling. While 
the mechanisms by which NF-kB activity promotes the effects here observed 
are not yet clear, these findings demonstrate the importance of this signalling 
pathway in the progression of this first stage of tumorigenesis. Finally, I 
provided evidence of heterogeneity within the recruited neutrophil population 
and the different behaviours they exhibit, setting the ground for future analysis 
of the specific role of different neutrophil subsets in tumour initiation. 
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Supplementary Figure 1 Construct map for krtt1c19e:KalTA4-ERT2 used for 
generation of transgenic zebrafish line. Designed and generated by Thomas 






Supplementary Figure 2 Construct map for lyz:lifeact-mTurquoise2a used for 
generation of transgenic zebrafish line. Designed and generated by Thomas 





Supplementary Figure 3 Construct map for UAS:eGFP/mCherry-HRASG12V 
used for microinjection into one-cell-stage eggs of krtt1c19e:KalTA4-ERT2. 
UAS:eGFP-HRASG12V designed and generated by Thomas Ramezani (Yi 




Supplementary Figure 4 Gating strategy for flow cytometry analysis of 
lyz:DsRed positive neutrophils in Tg(NFkB:eGFP) larvae. Following 
identification of fully dissociated single cells using FSC and SSC parameters 
in the detailed combinations, DsRed positive neutrophils were detected with 
YG582/15-A laser (DsRed+). B670/30-A laser was used to exclude 






Supplementary Figure 5 Gating strategy for flow cytometry analysis of 
lyz:lifeact-mturquoise2a positive neutrophils in Tg(myd88:DsRed2) larvae. 
Following identification of fully dissociated single cells using FSC and SSC 
parameters in the detailed combinations, mTurquoise positive neutrophils 
were detected with V450/50-A laser (mT+). B670/30-A laser was used to 
exclude autofluorescence (mT+ no auto). YG582/15-A laser was used to detect 





Supplementary Figure 6 PNC extrusion happens on rare occasions. A) Still 
images of a 5 hour long time-lapse video showing extensive interaction 
between two neighbouring PNCs. One PNC (2) is eventually extruded and sits 
on top of the other and eventually expands over the epithelium. B) Extruded 
cell (arrowhead) sits at the surface of the zebrafish larval skin (dotted line 
delineates basal skin layer) where it stays during a 3 hour long time-lapse 





Supplementary Figure 7 Construct map for dUAS: IkBSR;eGFP-HRasG12V to 
be used for microinjection into one-cell-stage eggs of krtt1c19e:KalTA4-ERT2. 
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